{
    "paper_id": "PMC6481281",
    "metadata": {
        "title": "Understanding Fc Receptor Involvement in Inflammatory Diseases: From Mechanisms to New Therapeutic Tools",
        "authors": [
            {
                "first": "Sanae",
                "middle": [],
                "last": "Ben Mkaddem",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Marc",
                "middle": [],
                "last": "Benhamou",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Renato",
                "middle": [
                    "C."
                ],
                "last": "Monteiro",
                "suffix": "",
                "email": null,
                "affiliation": {}
            }
        ]
    },
    "body_text": [
        {
            "text": "Immunoglobulin Fc receptors (FcRs) are membrane molecules expressed by several hematopoietic cells that recognize the Fc region of several immunoglobulin (Ig) classes and subclasses. We distinguish FcR for IgG (Fc\u03b3RI/CD64, Fc\u03b3RII/CD32, and Fc\u03b3RIII/CD16), IgE (Fc\u03f5RI), IgA (Fc\u03b1RI/CD89), IgM (Fc\u03bcR), and IgA/IgM (Fc\u03b1/\u03bcR). Several other receptors expressed on different cell types also bind Ig molecules: neonatal FcR for IgG (FcRn) on intestinal epithelium, placenta, and endothelium, low affinity Fc\u03f5R (Fc\u03f5RII/CD23) on B cells and macrophages, and polymeric Ig receptor (pIgR) on mucosal epithelium (1\u20133).",
            "cite_spans": [
                {
                    "start": 599,
                    "end": 600,
                    "mention": "1",
                    "ref_id": "BIBREF0"
                },
                {
                    "start": 601,
                    "end": 602,
                    "mention": "3",
                    "ref_id": "BIBREF53"
                }
            ],
            "section": "Fc receptor modes of action",
            "ref_spans": []
        },
        {
            "text": "The function of antibodies depends on one hand on their ability to recognize antigenic epitopes and, on the other hand, on their dynamic flexibility and their capacity to interact with their cognate FcRs. Engagement of FcRs expressed by leukocytes initiates a number of pro-inflammatory, anti-inflammatory, and immune modulatory functions in the host adaptive immune responses leading to protection but sometimes also to disease.",
            "cite_spans": [],
            "section": "Fc receptor modes of action",
            "ref_spans": []
        },
        {
            "text": "Several FcRs require the Immunoreceptor Tyrosine-based Activation Motif (ITAM; with the sequence Yxx[L/I]x(6\u22128)Yxx[L/I]) present in the cytoplasmic tail of the receptor or of associated subunits (FcR\u03b3 or Fc\u03b5RI\u03b2 chain) to induce cell signaling. ITAM-mediated functions include phagocytosis, degranulation, antibody-dependent cellular cytotoxicity (ADCC), cytokine, lipid mediator and superoxide production, all of which depend on the cell type and on outside-in signals induced by the ligand. Engagement of the type I FcRs by immune complexes, induces receptor aggregation followed by activation and recruitment of Src family kinases (SFKs), such as Lyn and Fyn (4). The former induces the phosphorylation of the conserved tyrosines in the ITAM motif, followed by activation and recruitment of the tyrosine kinase Syk. This process activates various proteins involved in cell response, such as Phospholipase C gamma 1 (PLC\u03b3), Bruton's tyrosine kinase (Btk), guanine nucleotide exchange factor Vav and phosphoinositide 3-kinase (PI3K). Hydrolysis of phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5) P2) by PLC\u03b3 generates inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (DAG) leading to calcium mobilization and protein kinase C (PKC) activation, respectively. Calcium influx and PKC activation promote cell responses such as degranulation and cytokine production. Vav plays also an important role in actin cytoskeleton remodeling to control phagocytosis and superoxide production by NADPH oxidase. PI3K catalyzes the phosphorylation of PtdIns(4,5)P2 into PtdIns(3,4,5)P3 in the plasma membrane. Pleckstrin homology domains contained in proteins such as PLC\u03b3, GRB2-associated-binding protein 2 (Gab2), protein kinase B (PKB/Akt) and Btk, bind PtdIns(3,4,5)P3 thus recruiting them at the inner leaflet of the plasma membrane promoting their phosphorylation and activation (Figure 1, left).",
            "cite_spans": [
                {
                    "start": 662,
                    "end": 663,
                    "mention": "4",
                    "ref_id": "BIBREF64"
                }
            ],
            "section": "Fc receptor modes of action",
            "ref_spans": [
                {
                    "start": 1877,
                    "end": 1885,
                    "mention": "Figure 1",
                    "ref_id": "FIGREF0"
                }
            ]
        },
        {
            "text": "The activation of ITAM-bearing immune receptors can be retro-controlled by ITIM-bearing inhibitory FcRs such as the Fc\u03b3RIIB. The ITIM motif is defined by a single [I/V/L/S]xYxx[L/V] sequence. However, inhibition of cell activation by this motif requires co-ligation between the inhibitory and heterologous activating receptors by immune complexes promoting the recruitment of inositol phosphatases (SHIP-1 and SHIP-2) (6) (Figure 1, Middle). Another inhibitory mechanism has been recently identified that involves ITAM itself. Indeed, following low avidity ligand interactions, ITAM-bearing FcRs induce a sustained inhibitory signal without co-ligation with heterologous receptors. This mechanism was involved in the maintenance of immune homeostasis (7\u201314). We named this ITAM-mediated inhibitory signal, ITAMi. It has been shown that several low affinity receptors, such as Fc\u03b1RI, Fc\u03b3RIIA and Fc\u03b3RIIIA, can function as such bi-functional receptors to induce either activating or inhibitory signals, a property that can be exploited to reduce the susceptibility to autoimmune and inflammatory diseases (11). Monovalent or divalent targeting of FcRs bearing an ITAM motif induced ITAMi signals that involved activation and recruitment of the Src homology region 2 domain-containing tyrosine phosphatase SHP-1 (Figure 1, Right). It has been demonstrated that other immunoreceptors such as the antigen receptors BCR and TCR can also associate with SHP-1 upon interaction with low avidity ligands (15, 16). Moreover, SHP-1 deficiency in hematopoietic cells favors development of various auto-immunes diseases. For example, the motheaten mice (mev/mev) which express approximately 20% wild type activity of SHP-1, develop severe immune dysregulation and autoantibody production (17).",
            "cite_spans": [
                {
                    "start": 419,
                    "end": 420,
                    "mention": "6",
                    "ref_id": "BIBREF86"
                },
                {
                    "start": 752,
                    "end": 753,
                    "mention": "7",
                    "ref_id": "BIBREF97"
                },
                {
                    "start": 754,
                    "end": 756,
                    "mention": "14",
                    "ref_id": "BIBREF36"
                },
                {
                    "start": 1104,
                    "end": 1106,
                    "mention": "11",
                    "ref_id": "BIBREF12"
                },
                {
                    "start": 1495,
                    "end": 1497,
                    "mention": "15",
                    "ref_id": "BIBREF37"
                },
                {
                    "start": 1499,
                    "end": 1501,
                    "mention": "16",
                    "ref_id": "BIBREF38"
                },
                {
                    "start": 1775,
                    "end": 1777,
                    "mention": "17",
                    "ref_id": "BIBREF39"
                }
            ],
            "section": "Fc receptor modes of action",
            "ref_spans": [
                {
                    "start": 423,
                    "end": 431,
                    "mention": "Figure 1",
                    "ref_id": "FIGREF0"
                },
                {
                    "start": 1310,
                    "end": 1318,
                    "mention": "Figure 1",
                    "ref_id": "FIGREF0"
                }
            ]
        },
        {
            "text": "During ITAMi signaling induced by FcRs, Lyn is essential for the phosphorylation (on tyrosine residue 536) and the activation of SHP-1 (4). It has been reported that Lyn is involved in positive and negative signals induced by antigen receptors (18, 19). Lyn plays an important role in the negative selection of B cells in the bone marrow, since the absence of Lyn was associated with a decreased B cell number in the periphery of mice. In the absence of Lyn, other SFKs, such as Fyn, act as positive regulators of BCR signaling, suggesting a loss of anergy. The opposite roles of Lyn and Fyn were recently demonstrated by in vivo approaches. Lyn deficiency aggravates auto/inflammatory diseases such as nephritis and arthritis, while the absence of Fyn protects against these diseases (4). Additionally, we showed that activation of leukocytes in lupus nephritis patients was associated with Fyn-activated signature, suggesting that the balance between Lyn and Fyn is dysregulated during diseases.",
            "cite_spans": [
                {
                    "start": 136,
                    "end": 137,
                    "mention": "4",
                    "ref_id": "BIBREF64"
                },
                {
                    "start": 245,
                    "end": 247,
                    "mention": "18",
                    "ref_id": "BIBREF40"
                },
                {
                    "start": 249,
                    "end": 251,
                    "mention": "19",
                    "ref_id": "BIBREF41"
                },
                {
                    "start": 786,
                    "end": 787,
                    "mention": "4",
                    "ref_id": "BIBREF64"
                }
            ],
            "section": "Fc receptor modes of action",
            "ref_spans": []
        },
        {
            "text": "Another FcR that play an essential role in the transcytosis by epithelial cells of dimeric IgA, but also pentameric IgM (notably during IgA deficiencies), is called the polymeric immunoglobulin receptor (pIgR). The pIgR is internalized with its ligands by endocytosis and transcytosed from the basolateral membrane into apical side of the epithelial cell (20). The central role of this receptor is to generate secretory IgA (formed of IgA dimers linked to the extracellular domain of the pIgR, also known as secretory component) in exocrine secretions to establish host-microbiota symbiosis and to mediate the protection of mucosal surfaces against pathogens (20, 21). The Fc\u03b1/\u03bcR, the Fc receptor for IgA and IgM, may play a role in systemic and mucosal immunity. It has been shown that none of the B cells, T cells, monocyte/macrophages, or NK cells in human blood samples expressed this receptor irrespective of age, ethnic origin or gender. Its expression is restricted to B cells from germinal center, follicular dendritic cells and tonsillar cells. Although, the exact function of the Fc\u03b1/\u03bcR is not fully clarified, it may play an important role in antigen presentation and B cell selection in the germinal center responses (22).",
            "cite_spans": [
                {
                    "start": 356,
                    "end": 358,
                    "mention": "20",
                    "ref_id": "BIBREF43"
                },
                {
                    "start": 660,
                    "end": 662,
                    "mention": "20",
                    "ref_id": "BIBREF43"
                },
                {
                    "start": 664,
                    "end": 666,
                    "mention": "21",
                    "ref_id": "BIBREF44"
                },
                {
                    "start": 1230,
                    "end": 1232,
                    "mention": "22",
                    "ref_id": "BIBREF45"
                }
            ],
            "section": "Fc receptor modes of action",
            "ref_spans": []
        },
        {
            "text": "FcRs are divided into type I and type II on the basis of the conformational state of the Ig Fc domain that interacts with the receptor (1, 23). Type I Fc receptors interact with \u201copen,\u201d but not \u201cclosed\u201d Ig Fc conformation (Figure 2). These receptors include Fc\u03b3RI, Fc\u03b3RII, Fc\u03b3RIII, Fc\u03b5RI, Fc\u03b1RI, Fc\u03bcR, and Fc\u03b1/\u03bcR (25\u2013 29). In contrast, type II FcRs, bind preferentially Ig Fc domains in \u201cclosed\u201d conformation. Among these are C-type lectin receptors such as Fc\u03b5RII (CD23) and DC-SIGN (Figure 3).",
            "cite_spans": [
                {
                    "start": 136,
                    "end": 137,
                    "mention": "1",
                    "ref_id": "BIBREF0"
                },
                {
                    "start": 139,
                    "end": 141,
                    "mention": "23",
                    "ref_id": "BIBREF46"
                },
                {
                    "start": 314,
                    "end": 316,
                    "mention": "25",
                    "ref_id": "BIBREF48"
                },
                {
                    "start": 318,
                    "end": 320,
                    "mention": "29",
                    "ref_id": "BIBREF52"
                }
            ],
            "section": "Fc receptor modes of action",
            "ref_spans": [
                {
                    "start": 223,
                    "end": 231,
                    "mention": "Figure 2",
                    "ref_id": "FIGREF1"
                },
                {
                    "start": 485,
                    "end": 493,
                    "mention": "Figure 3",
                    "ref_id": "FIGREF2"
                }
            ]
        },
        {
            "text": "For type II Fc receptors, glycosylation of the Fc domain induces a conformational change that occludes the binding site for type I Fc receptors that lies near the hinge region (open conformation) and reveals a binding site at the CH2-CH3 domain interface (closed conformation). These receptors bind antibodies in a two receptors-to-one antibody stoichiometry that may influence signal initiation (1). DC-SIGN and SIGN-R1, for example, bind secretory IgA and play an intriguing role in dendritic cells inducing IL10 and Treg-mediated tolerance (30). Signaling through these receptors, however, is not yet documented as compared to type I FcRs, with the exception of CD23. Crosslinking of CD23 on B cells activates cAMP (31) and intracellular calcium flux (32) which is associated with the activation of the SFK Fyn and of the PI3K pathway (33). These findings are in agreement with our recent data on type I FcRs (4), and indicates that Fyn also plays an activating role in B cells through type II Fc receptors.",
            "cite_spans": [
                {
                    "start": 397,
                    "end": 398,
                    "mention": "1",
                    "ref_id": "BIBREF0"
                },
                {
                    "start": 544,
                    "end": 546,
                    "mention": "30",
                    "ref_id": "BIBREF54"
                },
                {
                    "start": 719,
                    "end": 721,
                    "mention": "31",
                    "ref_id": "BIBREF55"
                },
                {
                    "start": 755,
                    "end": 757,
                    "mention": "32",
                    "ref_id": "BIBREF56"
                },
                {
                    "start": 839,
                    "end": 841,
                    "mention": "33",
                    "ref_id": "BIBREF57"
                },
                {
                    "start": 913,
                    "end": 914,
                    "mention": "4",
                    "ref_id": "BIBREF64"
                }
            ],
            "section": "Fc receptor modes of action",
            "ref_spans": []
        },
        {
            "text": "Several single-nucleotide polymorphisms (SNPs) have been reported in the genes encoding activating Fc\u03b3Rs (Fc\u03b3RIIA, Fc\u03b3RIIIA, and Fc\u03b3RIIIB). In the gene encoding the inhibitory Fc\u03b3RIIB, a SNP has been described which is associated with autoimmune diseases such as SLE and rheumatoid arthritis (RA) (34, 35). In addition to SNPs, copy-number variations (CNVs) of Fc\u03b3R genes are associated with susceptibility to autoimmune disorders (34\u201340). Most polymorphisms concern the extracellular domains which bind to IgG, affecting the affinity between these receptors and IgG subclasses. However, no polymorphism and CNV have been clearly identified for Fc\u03b3RI.",
            "cite_spans": [
                {
                    "start": 298,
                    "end": 300,
                    "mention": "34",
                    "ref_id": "BIBREF58"
                },
                {
                    "start": 302,
                    "end": 304,
                    "mention": "35",
                    "ref_id": "BIBREF59"
                },
                {
                    "start": 432,
                    "end": 434,
                    "mention": "34",
                    "ref_id": "BIBREF58"
                },
                {
                    "start": 435,
                    "end": 437,
                    "mention": "40",
                    "ref_id": "BIBREF65"
                }
            ],
            "section": "Gene Alleles ::: Fc Receptors and Diseases",
            "ref_spans": []
        },
        {
            "text": "The most studied polymorphism is the one in the second Ig-like extracellular domain of the Fc\u03b3RIIA that results in a point mutation of amino acid at position 131, coding for either arginine (R131) or histidine (H131). Fc\u03b3RIIA-R131 binds less efficiently IgG2 than Fc\u03b3RIIA-H131 (34). This Fcgr2a polymorphism has been described as a heritable risk factor for autoimmune and infectious diseases (41, 42). Moreover, genome-wide association studies (GWAS) revealed that Fc\u03b3RIIA-H131 variant is associated with higher susceptibilities to develop Kawasaki disease and ulcerative colitis (43, 44). This variant is also associated with Guillain\u2013Barr\u00e9 syndrome (45), supporting that immune complexes that include IgG2 auto-antibodies are involved in inflammatory responses. In contrast, the genotype homozygous for the Fc\u03b3RIIA-R131 variant-encoding gene is associated with SLE, immune thrombocytopenic purpura (ITP) and IgA nephropathy (IgAN), revealing a complex and contrasted picture for the role of IgG2-containing immune complexes in autoimmune diseases (46\u201348). Regarding infectious diseases, neutrophils homozygous for the gene encoding the H131 variant show a higher capacity for IgG2-mediated phagocytosis than those homozygous for the gene encoding the R131 variant (41). In agreement, patients with the R encoding allele were found to have more severe cases of Severe Acute Respiratory Syndrome infection and were more susceptible to encapsulated microorganism infection, which was attributed to poor IgG2 binding to the R131 variant of Fc\u03b3RIIA (41, 42). As mice do not express Fc\u03b3RIIA homologs, transgenic mice expressing the Fcgr2a human gene encoding the R131 variant develop spontaneously autoimmune diseases such as pneumonitis, glomerulonephritis and RA (49, 50). Moreover, the fact that Fc\u03b3RIIA-R131 expressed on the FcR\u03b3-/- background in mice similarly develop thrombocytopenia (51) and arthritis (11, 52) indicates that pro-autoimmune signals through Fc\u03b3RIIA-R131 ITAM were sufficient to induce diseases. Biochemical analyses showed that two tyrosines of Fc\u03b3RIIA ITAM motif were needed to induce inflammatory signals (53). Taken together, these animal models underline the critical involvement of Fcgr2a polymorphism in a number of diseases.",
            "cite_spans": [
                {
                    "start": 278,
                    "end": 280,
                    "mention": "34",
                    "ref_id": "BIBREF58"
                },
                {
                    "start": 394,
                    "end": 396,
                    "mention": "41",
                    "ref_id": "BIBREF66"
                },
                {
                    "start": 398,
                    "end": 400,
                    "mention": "42",
                    "ref_id": "BIBREF67"
                },
                {
                    "start": 582,
                    "end": 584,
                    "mention": "43",
                    "ref_id": "BIBREF68"
                },
                {
                    "start": 586,
                    "end": 588,
                    "mention": "44",
                    "ref_id": "BIBREF69"
                },
                {
                    "start": 653,
                    "end": 655,
                    "mention": "45",
                    "ref_id": "BIBREF70"
                },
                {
                    "start": 1051,
                    "end": 1053,
                    "mention": "46",
                    "ref_id": "BIBREF71"
                },
                {
                    "start": 1054,
                    "end": 1056,
                    "mention": "48",
                    "ref_id": "BIBREF73"
                },
                {
                    "start": 1268,
                    "end": 1270,
                    "mention": "41",
                    "ref_id": "BIBREF66"
                },
                {
                    "start": 1548,
                    "end": 1550,
                    "mention": "41",
                    "ref_id": "BIBREF66"
                },
                {
                    "start": 1552,
                    "end": 1554,
                    "mention": "42",
                    "ref_id": "BIBREF67"
                },
                {
                    "start": 1763,
                    "end": 1765,
                    "mention": "49",
                    "ref_id": "BIBREF74"
                },
                {
                    "start": 1767,
                    "end": 1769,
                    "mention": "50",
                    "ref_id": "BIBREF76"
                },
                {
                    "start": 1889,
                    "end": 1891,
                    "mention": "51",
                    "ref_id": "BIBREF77"
                },
                {
                    "start": 1908,
                    "end": 1910,
                    "mention": "11",
                    "ref_id": "BIBREF12"
                },
                {
                    "start": 1912,
                    "end": 1914,
                    "mention": "52",
                    "ref_id": "BIBREF78"
                },
                {
                    "start": 2129,
                    "end": 2131,
                    "mention": "53",
                    "ref_id": "BIBREF79"
                }
            ],
            "section": "Gene Alleles ::: Fc Receptors and Diseases",
            "ref_spans": []
        },
        {
            "text": "A polymorphism has been found in the inhibitory Fc\u03b3RIIB-encoding gene that leads to a single I-to-T amino acid substitution in the transmembrane domain (residue 232) (43, 54). Human monocytes expressing the Fc\u03b3RIIB-T232 failed to inhibit heterologous receptors-mediated cell activation (55). The Fc\u03b3RIIB-T232 polymorphism is associated with susceptibility to develop auto-immune diseases such as SLE (42, 54, 56). However, there are some discordances concerning the SNPs in the promoter region of Fcgr2b, such as \u2212386G and \u2212120T (haplotype 2B.2), and \u2212386C and \u2212120A (haplotype 2B.4) variants. It has been shown that the 2B.4 SNP promoter haplotype upregulates the expression of Fc\u03b3RIIB on neutrophils and monocytes that negatively correlates with lupus nephritis (46). This is in agreement with previous reports in mouse SLE-like models and suggests that Fc\u03b3RIIB expression is protective in SLE (57). However, in striking contrast and in an apparent paradox, the same 2B.4 promoter haplotype was found by the same authors to correlate with SLE (46). This positive (SLE) vs. negative (lupus nephritis) paradoxical association of the 2B.4 promoter haplotype suggests multifaceted impacts of Fc\u03b3RIIB in SLE that may depend on the affected cell types (e.g., monocytes vs. neutrophils). Alternatively, particular cell types expressing Fc\u03b3RIIB could have aggravating or protective actions in SLE depending on which affected tissue these cells are recruited to, or on how these cells impact the systemic vs. local aspect of the disease. Thus, further investigation is necessary to elucidate the association of the promoter haplotype in disease development.",
            "cite_spans": [
                {
                    "start": 167,
                    "end": 169,
                    "mention": "43",
                    "ref_id": "BIBREF68"
                },
                {
                    "start": 171,
                    "end": 173,
                    "mention": "54",
                    "ref_id": "BIBREF80"
                },
                {
                    "start": 287,
                    "end": 289,
                    "mention": "55",
                    "ref_id": "BIBREF81"
                },
                {
                    "start": 401,
                    "end": 403,
                    "mention": "42",
                    "ref_id": "BIBREF67"
                },
                {
                    "start": 405,
                    "end": 407,
                    "mention": "54",
                    "ref_id": "BIBREF80"
                },
                {
                    "start": 409,
                    "end": 411,
                    "mention": "56",
                    "ref_id": "BIBREF82"
                },
                {
                    "start": 765,
                    "end": 767,
                    "mention": "46",
                    "ref_id": "BIBREF71"
                },
                {
                    "start": 897,
                    "end": 899,
                    "mention": "57",
                    "ref_id": "BIBREF83"
                },
                {
                    "start": 1046,
                    "end": 1048,
                    "mention": "46",
                    "ref_id": "BIBREF71"
                }
            ],
            "section": "Gene Alleles ::: Fc Receptors and Diseases",
            "ref_spans": []
        },
        {
            "text": "The Fcgr3a polymorphism is characterized by a point mutation in the codon for residue 158, encoding valine (V158) or phenylalanine (F158) in the Ig-like domain near the membrane (34\u201336). The Fc\u03b3RIIIA-V158 variant has a higher affinity for all human IgGs than the Fc\u03b3RIIIA-F158 variant (40). The Fc\u03b3RIIIA-F158 is associated with susceptibility to SLE, Crohn's disease and Beh\u00e7et's disease (35, 36). Although studies have also explored the association between RA and the V or F 158 variant, their results have been contradictory and this question remains unsettled (58, 59).",
            "cite_spans": [
                {
                    "start": 179,
                    "end": 181,
                    "mention": "34",
                    "ref_id": "BIBREF58"
                },
                {
                    "start": 182,
                    "end": 184,
                    "mention": "36",
                    "ref_id": "BIBREF60"
                },
                {
                    "start": 286,
                    "end": 288,
                    "mention": "40",
                    "ref_id": "BIBREF65"
                },
                {
                    "start": 389,
                    "end": 391,
                    "mention": "35",
                    "ref_id": "BIBREF59"
                },
                {
                    "start": 393,
                    "end": 395,
                    "mention": "36",
                    "ref_id": "BIBREF60"
                },
                {
                    "start": 564,
                    "end": 566,
                    "mention": "58",
                    "ref_id": "BIBREF84"
                },
                {
                    "start": 568,
                    "end": 570,
                    "mention": "59",
                    "ref_id": "BIBREF85"
                }
            ],
            "section": "Gene Alleles ::: Fc Receptors and Diseases",
            "ref_spans": []
        },
        {
            "text": "Several Fcar1 polymorphisms have been found, including two in the functional promoter region of the Fc\u03b1RI encoding gene (\u2212114T/C and +56T/C relative to the major transcription start site) (60). The incidence of the \u2212114C/C polymorphism in patients with IgAN was significantly increased compared with other chronic kidney diseases (CKD) and healthy donors (HD) (15.6 vs. 4.0% in other CKD and vs. 2.4% in HD). This Fcar1 polymorphism in the promoter region appears to be associated with susceptibility to IgAN, suggesting the importance of Fc\u03b1RI expression in this disease. A third Fcar1 polymorphism has been described in the coding region for Fc\u03b1RI, which changes codon 248 from AGC to GGC leading to G248 instead of S248 in the cytoplasmic domain of the receptor (61). Interestingly, these two different alleles demonstrate significantly different Fc\u03b1RI-mediated intracellular activating signaling. The proinflammatory Fc\u03b1RI-G248 variant has been associated with SLE in two ethnic groups (61). However, this Fcar1 polymorphism was not associated with other auto-immune diseases such as systemic sclerosis, RA or IgAN (62, 63). A fourth Fcar1 polymorphism (A/G at nt 324) was also associated with aggressive periodontitis (64). Patients displaying the nt 324 A/A allele presented polymorphonuclear neutrophil dysfunctions with a decreased phagocytosis of periodontopathic bacteria (Porphyromonas gingivalis) as compared to patients expressing the nt 324 G/G (64).",
            "cite_spans": [
                {
                    "start": 189,
                    "end": 191,
                    "mention": "60",
                    "ref_id": "BIBREF87"
                },
                {
                    "start": 766,
                    "end": 768,
                    "mention": "61",
                    "ref_id": "BIBREF88"
                },
                {
                    "start": 991,
                    "end": 993,
                    "mention": "61",
                    "ref_id": "BIBREF88"
                },
                {
                    "start": 1120,
                    "end": 1122,
                    "mention": "62",
                    "ref_id": "BIBREF89"
                },
                {
                    "start": 1124,
                    "end": 1126,
                    "mention": "63",
                    "ref_id": "BIBREF90"
                },
                {
                    "start": 1224,
                    "end": 1226,
                    "mention": "64",
                    "ref_id": "BIBREF91"
                },
                {
                    "start": 1460,
                    "end": 1462,
                    "mention": "64",
                    "ref_id": "BIBREF91"
                }
            ],
            "section": "Gene Alleles ::: Fc Receptors and Diseases",
            "ref_spans": []
        },
        {
            "text": "Regarding the pIgR, it has been reported as a susceptibility gene for nasopharyngeal cancer (NPC) associated with Epstein-Barr virus (EBV) (65). This lead to a hypothesis that pIgR could be the nasopharyngeal epithelial receptor for EBV via IgA-EBV complex. Transcytosis failure due to missense C \u2192 T mutation on the PIGR1739 nucleotide (resulting in an A-to-V mutation near the endoproteolytic cleavage site of pIgR) could decrease the ability of pIgR to release IgA-EBV complexes, thus increasing susceptibility to develop NPC (65).",
            "cite_spans": [
                {
                    "start": 140,
                    "end": 142,
                    "mention": "65",
                    "ref_id": "BIBREF92"
                },
                {
                    "start": 530,
                    "end": 532,
                    "mention": "65",
                    "ref_id": "BIBREF92"
                }
            ],
            "section": "Gene Alleles ::: Fc Receptors and Diseases",
            "ref_spans": []
        },
        {
            "text": "The high-affinity Fc\u03b5RI is expressed by mast cells and basophils and plays an important role in allergic diseases. Several studies have identified two Fc\u03b5RI polymorphisms associated with allergies. The \u221266T > C and/or the \u2212315C > T are associated with atopic dermatitis, chronic urticaria, asthma, and high serum IgE levels (66\u201369). These polymorphisms were also associated with allergic inflammatory diseases such as atopy and nasal allergy (70, 71).",
            "cite_spans": [
                {
                    "start": 325,
                    "end": 327,
                    "mention": "66",
                    "ref_id": "BIBREF93"
                },
                {
                    "start": 328,
                    "end": 330,
                    "mention": "69",
                    "ref_id": "BIBREF96"
                },
                {
                    "start": 443,
                    "end": 445,
                    "mention": "70",
                    "ref_id": "BIBREF98"
                },
                {
                    "start": 447,
                    "end": 449,
                    "mention": "71",
                    "ref_id": "BIBREF99"
                }
            ],
            "section": "Gene Alleles ::: Fc Receptors and Diseases",
            "ref_spans": []
        },
        {
            "text": "Table 1 summarizes most of described FcR alleles and their expression and functions in physiology and pathology (42\u201344, 46, 48, 60, 65, 66, 69, 72\u201383).",
            "cite_spans": [
                {
                    "start": 113,
                    "end": 115,
                    "mention": "42",
                    "ref_id": "BIBREF67"
                },
                {
                    "start": 116,
                    "end": 118,
                    "mention": "44",
                    "ref_id": "BIBREF69"
                },
                {
                    "start": 120,
                    "end": 122,
                    "mention": "46",
                    "ref_id": "BIBREF71"
                },
                {
                    "start": 124,
                    "end": 126,
                    "mention": "48",
                    "ref_id": "BIBREF73"
                },
                {
                    "start": 128,
                    "end": 130,
                    "mention": "60",
                    "ref_id": "BIBREF87"
                },
                {
                    "start": 132,
                    "end": 134,
                    "mention": "65",
                    "ref_id": "BIBREF92"
                },
                {
                    "start": 136,
                    "end": 138,
                    "mention": "66",
                    "ref_id": "BIBREF93"
                },
                {
                    "start": 140,
                    "end": 142,
                    "mention": "69",
                    "ref_id": "BIBREF96"
                },
                {
                    "start": 144,
                    "end": 146,
                    "mention": "72",
                    "ref_id": "BIBREF100"
                },
                {
                    "start": 147,
                    "end": 149,
                    "mention": "83",
                    "ref_id": "BIBREF112"
                }
            ],
            "section": "Gene Alleles ::: Fc Receptors and Diseases",
            "ref_spans": [
                {
                    "start": 0,
                    "end": 7,
                    "mention": "Table 1",
                    "ref_id": "TABREF0"
                }
            ]
        },
        {
            "text": "Several studies highlighted altered expression, structure and function of Fc\u03b3Rs in patients. Whereas, CD4+ T cells from healthy donors fail to express significant levels of Fc\u03b3R, Fc\u03b3RIIA is expressed in a subpopulation of CD4+ T cells in blood samples from HIV-1-positive patients and is highly enriched in inducible replication-competent proviruses suggestive of an Fc\u03b3RIIA+ HIV reservoir (84). Yet, in other studies, Fc\u03b3RIIA expression did not selectively enrich for HIV- or SIV-infected CD4+ T cells in peripheral blood or lymphoid tissue since resting Fc\u03b3RIIA+ CD4+ T cells have <3% of the total HIV DNA amongst CD4+ T cells (85, 86). Taken together, whereas Fc\u03b3RIIA expression in CD4+ T cells becomes a marker for HIV infection, the involvement of Fc\u03b3RIIA+ CD4+ T cells in AIDS remains to be elucidated.",
            "cite_spans": [
                {
                    "start": 391,
                    "end": 393,
                    "mention": "84",
                    "ref_id": "BIBREF113"
                },
                {
                    "start": 630,
                    "end": 632,
                    "mention": "85",
                    "ref_id": "BIBREF114"
                },
                {
                    "start": 634,
                    "end": 636,
                    "mention": "86",
                    "ref_id": "BIBREF115"
                }
            ],
            "section": "Alterations in FcR Expression ::: Fc Receptors and Diseases",
            "ref_spans": []
        },
        {
            "text": "The inhibitory Fc\u03b3RIIB, in contrast, is down-regulated in autoimmune diseases notably on both memory and plasma B lymphocytes of active SLE patients compared to those from healthy individuals (87). However, this down-regulation was not seen on myeloid-lineage cells. This was also observed in Hashimoto's thyroiditis (88).",
            "cite_spans": [
                {
                    "start": 193,
                    "end": 195,
                    "mention": "87",
                    "ref_id": "BIBREF116"
                },
                {
                    "start": 318,
                    "end": 320,
                    "mention": "88",
                    "ref_id": "BIBREF117"
                }
            ],
            "section": "Alterations in FcR Expression ::: Fc Receptors and Diseases",
            "ref_spans": []
        },
        {
            "text": "High level of Fc\u03b3RIIIA expression on monocytes together with that of CD14 is associated with proinflammatory cytokine profiles and higher potency in antigen presentation allowing to define monocyte subsets with distinct phenotypes and functions (89).",
            "cite_spans": [
                {
                    "start": 246,
                    "end": 248,
                    "mention": "89",
                    "ref_id": "BIBREF118"
                }
            ],
            "section": "Alterations in FcR Expression ::: Fc Receptors and Diseases",
            "ref_spans": []
        },
        {
            "text": "For Fc\u03b1RI, its expression is dysregulated in patients with AIDS, ankylosing spondylitis, alcoholic liver cirrhosis, Henoch-Schonlein purpura (HSP) and IgAN (90\u201393). Some of these studies have shown biochemical abnormalities revealing Fc\u03b1RI altered protein mobility in SDS-PAGE suggesting altered glycosylation of this receptor (90). Interestingly, mutational studies of Fc\u03b1RI indicate that the N58 residue of the receptor controls IgA-binding enhancement (94). In parallel, abnormally glycosylated IgA1 molecules (hypogalactosylation and hyposialylation on the hinge region) observed in patients with IgAN and HSP is associated with the shedding of a soluble form of Fc\u03b1RI (sFc\u03b1RI), which participates in the formation of circulating IgA1 complexes (95). These IgA1-sFc\u03b1RI complexes were decreased in serum of IgAN patients with severe and progressive disease as compared to non-progressive IgAN patients (96) suggesting a kidney deposition, and hence a possible nephrotoxic action, of such complexes which is further supported by studies in IgAN patients with recurrence of the disease after kidney transplantation (97). In this study, IgA-sFc\u03b1RI complexes were decreased in the serum of patients with recurrent IgAN and sFc\u03b1RI was detected in the kidney mesangium only in patients with the recurrent disease. Direct evidence for a nephrotoxic role of IgA1-sFc\u03b1RI complexes were obtained in humanized animal models. These experimental studies were based on the fact that mouse do not have homologs of IgA1 and Fc\u03b1RI. Humanized mice expressing human IgA1 and human Fc\u03b1RI spontaneously develop mesangial deposits of IgA1-sFc\u03b1RI complexes (98). In the glomeruli, these complexes are captured by the transferrin receptor 1 (TfR1), which is upregulated on mesangial cells, through interaction with polymeric (p) IgA1 and Fc\u03b1RI (98, 99). Although the mechanism of TfR1 upregulation remains poorly understood, the crosslinking enzyme transglutaminase 2 has been found to be overexpressed and associated with the receptor controlling mesangial IgA1 complex deposition and renal injury (98). Polymeric IgA1 induce TfR1 expression in vitro on mesangial cells. Polymeric IgA1-TfR1 interaction triggers activating signals through mTOR, PI3K and ERK pathways, and phosphorylated ERK is associated with disease progression (100). Interestingly enough, in physiology TfR1-IgA1 interaction plays a role in erythropoiesis (101). Progression of IgAN to end-stage renal disease may also involve Fc\u03b1RI activation on tissue macrophages surrounding hypogalactosylated IgA1-mediated mesangial lesions. Indeed, Fc\u03b1RIR209LTg mice, with an R-to-L substitution at position 209 in the transmembrane region of Fc\u03b1RI, did not develop macrophage infiltration and proteinuria (102). This mutant receptor cannot associate with the ITAM-bearing FcR\u03b3 signaling subunit (103). In agreement, only macrophages expressing wild-type Fc\u03b1RI, but not those expressing Fc\u03b1RIR209L, were able to migrate to the kidney after adoptive transfer demonstrating that their chemotaxis depends on the FcR\u03b3 subunit. Of note, Fc\u03b1RI can be found associated and non-associated with FcR\u03b3 on the same cells (95). Since mouse IgA and human Fc\u03b1RI interaction may be sufficient to induce receptor shedding leading to IgA deposits in the kidney, we hypothesized that both receptor types could cooperate to induce disease, the FcR\u03b3-less Fc\u03b1RI allowing IgA deposits and the FcR\u03b3-associated Fc\u03b1RI promoting inflammatory cell infiltration and disease progression (102).",
            "cite_spans": [
                {
                    "start": 157,
                    "end": 159,
                    "mention": "90",
                    "ref_id": "BIBREF120"
                },
                {
                    "start": 160,
                    "end": 162,
                    "mention": "93",
                    "ref_id": "BIBREF123"
                },
                {
                    "start": 328,
                    "end": 330,
                    "mention": "90",
                    "ref_id": "BIBREF120"
                },
                {
                    "start": 456,
                    "end": 458,
                    "mention": "94",
                    "ref_id": "BIBREF124"
                },
                {
                    "start": 750,
                    "end": 752,
                    "mention": "95",
                    "ref_id": "BIBREF125"
                },
                {
                    "start": 906,
                    "end": 908,
                    "mention": "96",
                    "ref_id": "BIBREF126"
                },
                {
                    "start": 1117,
                    "end": 1119,
                    "mention": "97",
                    "ref_id": "BIBREF127"
                },
                {
                    "start": 1638,
                    "end": 1640,
                    "mention": "98",
                    "ref_id": "BIBREF128"
                },
                {
                    "start": 1824,
                    "end": 1826,
                    "mention": "98",
                    "ref_id": "BIBREF128"
                },
                {
                    "start": 1828,
                    "end": 1830,
                    "mention": "99",
                    "ref_id": "BIBREF129"
                },
                {
                    "start": 2079,
                    "end": 2081,
                    "mention": "98",
                    "ref_id": "BIBREF128"
                },
                {
                    "start": 2311,
                    "end": 2314,
                    "mention": "100",
                    "ref_id": "BIBREF2"
                },
                {
                    "start": 2407,
                    "end": 2410,
                    "mention": "101",
                    "ref_id": "BIBREF3"
                },
                {
                    "start": 2746,
                    "end": 2749,
                    "mention": "102",
                    "ref_id": "BIBREF4"
                },
                {
                    "start": 2836,
                    "end": 2839,
                    "mention": "103",
                    "ref_id": "BIBREF5"
                },
                {
                    "start": 3149,
                    "end": 3151,
                    "mention": "95",
                    "ref_id": "BIBREF125"
                },
                {
                    "start": 3497,
                    "end": 3500,
                    "mention": "102",
                    "ref_id": "BIBREF4"
                }
            ],
            "section": "Alterations in FcR Expression ::: Fc Receptors and Diseases",
            "ref_spans": []
        },
        {
            "text": "For Fc\u03bcR (IgM receptor), deficiency in the receptor in mice revealed that this receptor plays a crucial role in B cell responses (27, 104). Mice deficient for Fcmr are characterized by the increase in pre-immune serum IgM, dysregulation of humoral immune responses, disturbances in B cell subpopulations, B cell proliferation alteration after BCR ligation, and autoantibody production (104, 105). Accordingly, in chronic lymphocytic leukemia (CLL), the membrane expression and the soluble form of Fc\u03bcR in serum were increased. The potential mechanism proposed for the up-regulation of Fc\u03bcR is that the antigen-independent self-ligation of BCR on CLL cells induces activation of Syk thus increasing the cell surface expression of Fc\u03bcR. Furthermore, the IgM antibodies produced by CLL cells that had differentiated into plasma cells, recognized soluble or lymphocyte membrane self-antigens. IgM/self-antigen immune complexes would then crosslink Fc\u03bcR and BCR favoring cell survival. An alternative splice variant of the soluble Fc\u03bcR is increased in CLL patients, but its biological function is unclear (105, 106).",
            "cite_spans": [
                {
                    "start": 130,
                    "end": 132,
                    "mention": "27",
                    "ref_id": "BIBREF50"
                },
                {
                    "start": 134,
                    "end": 137,
                    "mention": "104",
                    "ref_id": "BIBREF6"
                },
                {
                    "start": 386,
                    "end": 389,
                    "mention": "104",
                    "ref_id": "BIBREF6"
                },
                {
                    "start": 391,
                    "end": 394,
                    "mention": "105",
                    "ref_id": "BIBREF7"
                },
                {
                    "start": 1101,
                    "end": 1104,
                    "mention": "105",
                    "ref_id": "BIBREF7"
                },
                {
                    "start": 1106,
                    "end": 1109,
                    "mention": "106",
                    "ref_id": "BIBREF8"
                }
            ],
            "section": "Alterations in FcR Expression ::: Fc Receptors and Diseases",
            "ref_spans": []
        },
        {
            "text": "For type II FcRs, an increased expression of Fc\u03b5RII on monocytes in AIDS patients has been associated with the aberrant activated phenotype of these cells during the immunopathogenesis of AIDS. Interestingly, despite the known ability of IL-10 to downregulate monocyte Fc\u03b5RII expression, in AIDS the IL-10-enriched environment is not associated with the suppression of Fc\u03b5RII expression on monocytes (82) indicative of an impairment of this negative regulation in patients. In B-CLL also, patients strongly express Fc\u03b5RII, which is associated with B cell activation and proliferation. Moreover, altered phosphorylation of Fc\u03b5RII intracellular tail were reported in B-CLL B lymphocytes (107) further supporting an active role of Fc\u03b5RII in this disease.",
            "cite_spans": [
                {
                    "start": 401,
                    "end": 403,
                    "mention": "82",
                    "ref_id": "BIBREF111"
                },
                {
                    "start": 686,
                    "end": 689,
                    "mention": "107",
                    "ref_id": "BIBREF9"
                }
            ],
            "section": "Alterations in FcR Expression ::: Fc Receptors and Diseases",
            "ref_spans": []
        },
        {
            "text": "Both murine models and studies in patients suggest a major role of the activating FcRs in initiating and propelling immune complex-mediated inflammatory reactions. For example, human Fc\u03b3RIIA transgenic mice are hypersensitive to pathogenic antibodies and develop destructive arthritic syndromes. Ex vivo experimentation with circulating monocytes from RA patients suggest that Fc\u03b3RIIA is responsible for the production of reactive oxygen species (11, 108). Anti-receptor monoclonal antibodies, intact antibodies and antibody fragments as well as a variety of small molecules have been designed to interact with the Ig-binding domains in activating FcRs. Some of these approaches have shown encouraging results when tested in vitro or in vivo for blocking immune complex-mediated cell effects and inflammation. Recently, we have demonstrated that divalent targeting of Fc\u03b3RIIA by anti-hFc\u03b3RII F(ab)\u20322 fragments ameliorates RA-associated inflammation. This therapeutic effect was mediated by the induction of inhibitory ITAM (ITAMi) signaling through the activation of SHP-1. Moreover, treatment of inflammatory synovial cells from RA patients by F(ab\u2032)2 fragment of hFc\u03b3RIIA-specific antibody inhibited production of reactive oxygen species associated with the induction of Fc\u03b3RIIA-mediated ITAMi signaling. These data suggest that targeting of hFc\u03b3RIIA by specific antibody such as clone IV.3 mAb could ameliorate RA-associated inflammation (11). Anti-Fc\u03b1RI Fab and F(ab)\u20322 fragments also have demonstrated efficiency on RA (109). Interestingly, in autoimmune blistering skin diseases that involve interaction between IgA autoantibodies and the neutrophil Fc\u03b1RI, targeting Fc\u03b1RI by blocking peptides or antibodies prevents neutrophil migration and tissue damage ex-vivo (110, 111).",
            "cite_spans": [
                {
                    "start": 447,
                    "end": 449,
                    "mention": "11",
                    "ref_id": "BIBREF12"
                },
                {
                    "start": 451,
                    "end": 454,
                    "mention": "108",
                    "ref_id": "BIBREF10"
                },
                {
                    "start": 1442,
                    "end": 1444,
                    "mention": "11",
                    "ref_id": "BIBREF12"
                },
                {
                    "start": 1525,
                    "end": 1528,
                    "mention": "109",
                    "ref_id": "BIBREF11"
                },
                {
                    "start": 1771,
                    "end": 1774,
                    "mention": "110",
                    "ref_id": "BIBREF13"
                },
                {
                    "start": 1776,
                    "end": 1779,
                    "mention": "111",
                    "ref_id": "BIBREF14"
                }
            ],
            "section": "Antibodies ::: Blocking/neutralizing Activating Receptor ::: Targeting of Fc Receptors as Therapeutic Approaches",
            "ref_spans": []
        },
        {
            "text": "In allergy, treatment by anti-IgE antibodies has been considered a therapeutic option for a long time. The recombinant anti-IgE humanized monoclonal antibody-E25, named \u201comalizumab,\u201d is now used in several clinical trials and shows efficacy against IgE-mediated allergic reactions (112, 113) through inhibition of IgE binding to Fc\u03b5RI on the surface of mast cells and basophils (113).",
            "cite_spans": [
                {
                    "start": 282,
                    "end": 285,
                    "mention": "112",
                    "ref_id": "BIBREF15"
                },
                {
                    "start": 287,
                    "end": 290,
                    "mention": "113",
                    "ref_id": "BIBREF16"
                },
                {
                    "start": 379,
                    "end": 382,
                    "mention": "113",
                    "ref_id": "BIBREF16"
                }
            ],
            "section": "Antibodies ::: Blocking/neutralizing Activating Receptor ::: Targeting of Fc Receptors as Therapeutic Approaches",
            "ref_spans": []
        },
        {
            "text": "The above-described upregulation of Fc\u03bcR expression in CLL cells is of significant clinical interest. It can be easily evaluated by flow cytometry on cells and, additionally, the levels of soluble Fc\u03bcR may correlate with disease progression. Thus, it may be used as a new biomarker for CLL (106). Fc\u03bcR is a good target also because it is involved in the pathogenesis of CLL and in the progression of the disease through support of leukemic cell survival (80). Hence, disrupting CLL survival signals might be achieved through Fc\u03bcR therapeutic targeting. However, a large cohort of CLL patients will be required to validate these two applications (106).",
            "cite_spans": [
                {
                    "start": 291,
                    "end": 294,
                    "mention": "106",
                    "ref_id": "BIBREF8"
                },
                {
                    "start": 455,
                    "end": 457,
                    "mention": "80",
                    "ref_id": "BIBREF109"
                },
                {
                    "start": 646,
                    "end": 649,
                    "mention": "106",
                    "ref_id": "BIBREF8"
                }
            ],
            "section": "Antibodies ::: Blocking/neutralizing Activating Receptor ::: Targeting of Fc Receptors as Therapeutic Approaches",
            "ref_spans": []
        },
        {
            "text": "Intravenous immunoglobulins (IVIG) are harvested from the pooled plasma of 3,000 to 100,000 healthy donors. They consist of over 95% IgGs with a subclass distribution corresponding to that found in normal human serum (114). IVIG is used in treatment of several immunodeficiency diseases including idiopathic thrombocytopenic purpura (ITP), Kawasaki disease, and neurologic diseases such as Guillain\u2013Barre syndrome, chronic inflammatory demyelinating polyneuropathy, myasthenia gravis, sclerosis, and autoimmune encephalitis (115). In ITP patients, administration of IVIG can efficiently attenuate platelet clearance from the circulation. The first proposed mechanism was the competitive blockage of the activating Fc\u03b3Rs on myeloid cells by IVIG, which in turn decreases autoantibody-mediated platelet phagocytosis and ADCC against platelets (116). Furthermore, in pediatric ITP patients, intravenous administration of the Fc\u03b3 fragments prepared from IVIG resulted in a rapid recovery in platelet counts (117) further indicating the role of Fc\u03b3Rs in IVIG action. Another IVIG anti-inflammatory mechanism involves saturation of FcRn, the IgG recycling receptor (118). FcRn plays an important role in the maintenance of IgG half-life. Therefore, inhibition of autoantibody activity can be induced by the alteration of their interaction with FcRn, impairing their half-life and accelerating their clearing from the circulation. IVIG by competing with autoantibodies for FcRn binding could therefore facilitate their clearing.",
            "cite_spans": [
                {
                    "start": 218,
                    "end": 221,
                    "mention": "114",
                    "ref_id": "BIBREF17"
                },
                {
                    "start": 525,
                    "end": 528,
                    "mention": "115",
                    "ref_id": "BIBREF18"
                },
                {
                    "start": 842,
                    "end": 845,
                    "mention": "116",
                    "ref_id": "BIBREF19"
                },
                {
                    "start": 1004,
                    "end": 1007,
                    "mention": "117",
                    "ref_id": "BIBREF20"
                },
                {
                    "start": 1160,
                    "end": 1163,
                    "mention": "118",
                    "ref_id": "BIBREF21"
                }
            ],
            "section": "IVIG ::: Blocking/neutralizing Activating Receptor ::: Targeting of Fc Receptors as Therapeutic Approaches",
            "ref_spans": []
        },
        {
            "text": "A role for the inhibitory Fc\u03b3RIIB has been proposed to be exclusive in IVIG action to explain their Fc dependent effect (118). This statement was based notably on studies showing a decreased anti-inflammatory effect of IVIG in Fc\u03b3RIIB-deficient animals. In other studies, a role for Fc\u03b3RIII in IVIG-mediated inhibition has been reported (119) although the mechanism of action was not clearly established. Recently, we reported that IVIG can control inflammatory responses by ITAMi signaling through Fc\u03b3RIIA and Fc\u03b3RIII (10, 11). These data are based on the in vitro targeting of Fc\u03b3RIIA and Fc\u03b3RIII by IVIG at the physiological concentration of IgG showing an inhibitory effect on endocytosis. This was confirmed by targeting Fc\u03b3RIIA or Fc\u03b3RIII with F(ab\u2032)2 fragments of specific antibodies. These results were further supported in vivo in mice by targeting these receptors with IVIG or with specific antibodies and this inhibitory effect was abolished in receptor-deficient mice (10, 11). Therefore, IVIG could use a combination of non-exclusive mechanisms to promote protection against auto-immune diseases. Although IVIG is well tolerated, some patients develop immediate or delayed adverse effects depending on the time occurrence. The Flu-like symptoms such as fever, fatigue and nausea are the most frequent adverse effects. For the delayed adverse effects, the most frequent are thrombotic events, neurological disorders and renal failure. These delayed adverse effects are rare but dangerous (120). The majority of adverse effects are associated with high doses of immunoglobulins; thus, determining individual dosages to guarantee the efficacy of therapy and minimize adverse effects is an urgent goal.",
            "cite_spans": [
                {
                    "start": 121,
                    "end": 124,
                    "mention": "118",
                    "ref_id": "BIBREF21"
                },
                {
                    "start": 338,
                    "end": 341,
                    "mention": "119",
                    "ref_id": "BIBREF22"
                },
                {
                    "start": 520,
                    "end": 522,
                    "mention": "10",
                    "ref_id": "BIBREF1"
                },
                {
                    "start": 524,
                    "end": 526,
                    "mention": "11",
                    "ref_id": "BIBREF12"
                },
                {
                    "start": 981,
                    "end": 983,
                    "mention": "10",
                    "ref_id": "BIBREF1"
                },
                {
                    "start": 985,
                    "end": 987,
                    "mention": "11",
                    "ref_id": "BIBREF12"
                },
                {
                    "start": 1501,
                    "end": 1504,
                    "mention": "120",
                    "ref_id": "BIBREF24"
                }
            ],
            "section": "IVIG ::: Blocking/neutralizing Activating Receptor ::: Targeting of Fc Receptors as Therapeutic Approaches",
            "ref_spans": []
        },
        {
            "text": "Treatment with highly purified serum monomeric IgA (mIgA) decreases cell activation through Fc\u03b1RI-FcR\u03b3-mediated ITAMi signaling (109). Human mIgA or anti-Fc\u03b1RI Fab fragments were used to prevent or treat collagen antibody-induced arthritis in Fc\u03b1RI-transgenic mice. mIgA treatment decreased significantly leukocyte infiltration to the inflamed joints of mice, which was associated with SHP-1 phosphorylation at Y536 residue in joint tissue cells. Moreover, mIgA reversed the activating ITAM to ITAMi signature and the state of inflammation in the synovial fluid isolated from RA patients (109). Of note, protection was also achieved with human serum IgA (4). These findings open new avenues to develop the concept of IVIgA as a new treatment option for inflammatory and auto-immune diseases.",
            "cite_spans": [
                {
                    "start": 129,
                    "end": 132,
                    "mention": "109",
                    "ref_id": "BIBREF11"
                },
                {
                    "start": 589,
                    "end": 592,
                    "mention": "109",
                    "ref_id": "BIBREF11"
                },
                {
                    "start": 655,
                    "end": 656,
                    "mention": "4",
                    "ref_id": "BIBREF64"
                }
            ],
            "section": "IVIG ::: Blocking/neutralizing Activating Receptor ::: Targeting of Fc Receptors as Therapeutic Approaches",
            "ref_spans": []
        },
        {
            "text": "The only FcR containing an inhibitory ITIM motif, Fc\u03b3RIIB, serves as a critical negative regulator in immune complex driven reactions. In mice lacking Fc\u03b3RIIB auto-immune symptoms are exacerbated, and a partial restoration of Fc\u03b3RIIB expression in B cells rescued mice from developing an SLE-like phenotype (57, 121). Several Fc\u03b3RIIB specific mAbs have now been developed (122, 123), one of which, mAb2B6, has been chimerized and humanized to direct myeloid-cytotoxicity against B cells (123). These antibodies have the potential to serve as novel immune suppressors in auto-immunity either by blocking B cell activation or by targeting their destruction. In addition, they may have an advantage over CD20 antibodies for their ability to target plasma cells (124).",
            "cite_spans": [
                {
                    "start": 308,
                    "end": 310,
                    "mention": "57",
                    "ref_id": "BIBREF83"
                },
                {
                    "start": 312,
                    "end": 315,
                    "mention": "121",
                    "ref_id": "BIBREF25"
                },
                {
                    "start": 373,
                    "end": 376,
                    "mention": "122",
                    "ref_id": "BIBREF26"
                },
                {
                    "start": 378,
                    "end": 381,
                    "mention": "123",
                    "ref_id": "BIBREF27"
                },
                {
                    "start": 488,
                    "end": 491,
                    "mention": "123",
                    "ref_id": "BIBREF27"
                },
                {
                    "start": 759,
                    "end": 762,
                    "mention": "124",
                    "ref_id": "BIBREF28"
                }
            ],
            "section": "Engagement of the Inhibitory Fc\u03b3RIIB (Agonist) ::: Targeting of Fc Receptors as Therapeutic Approaches",
            "ref_spans": []
        },
        {
            "text": "Blocking FcRn-IgG interaction to decrease circulating IgG levels is one strategy to treat auto-immune disease (118). In the absence of interaction with FcRn, IgG would be degraded in lysosomes more quickly instead of being recycled back into circulation. One straightforward method would be to use recombinant soluble human FcRn to compete with membrane FcRn for IgG. Another approach to block IgG-FcRn binding would be through engineered \u201cbait\u201d IgG which occupy FcRn thus preventing binding of endogenous IgG. Such \u201cbait\u201d antibodies have been generated with a much higher affinity for FcRn at both acidic and neutral pH, thereby providing effective occupancy of FcRn, competing with, and resulting in, degradation of endogenous IgG. These antibodies are also called \u201cAbdegs\u201d: antibodies that enhance IgG degradation (125).",
            "cite_spans": [
                {
                    "start": 111,
                    "end": 114,
                    "mention": "118",
                    "ref_id": "BIBREF21"
                },
                {
                    "start": 818,
                    "end": 821,
                    "mention": "125",
                    "ref_id": "BIBREF29"
                }
            ],
            "section": "Targeting FcRn ::: Targeting of Fc Receptors as Therapeutic Approaches",
            "ref_spans": []
        },
        {
            "text": "An FcRn-specific blocking mAb would also provide interference with FcRn-IgG interaction. One such mAb, 1G3, was examined in rat passive and active models of myasthenia gravis, a prototypical antibody-mediated auto-immune disease (126). Treatment by 1G3 mAb resulted in amelioration of disease symptoms in a dose-dependent manner together with greatly reduced levels of pathogenic antibody in the serum.",
            "cite_spans": [
                {
                    "start": 230,
                    "end": 233,
                    "mention": "126",
                    "ref_id": "BIBREF30"
                }
            ],
            "section": "Targeting FcRn ::: Targeting of Fc Receptors as Therapeutic Approaches",
            "ref_spans": []
        },
        {
            "text": "Targeting of FcRs by monomeric immunoglobulins or by F(ab\u2032)2 fragments of specific antibodies, induces ITAMi signaling which involved the recruitment of Lyn, but not Fyn. The Src kinase Lyn, leads to partial phosphorylation of the ITAM motif on tyrosine residues (11), and to the conformational change of SHP-1 that allows its recruitment through its SH2 domains to ITAM phosphotyrosine residues (127). This recruitment induces a Lyn-dependent phosphorylation of SHP-1 on Y536 and to SHP-1 phosphatase activity that inhibits the recruitment of various proteins induced by heterologous receptors (52). In contrast, multivalent crosslinking of immunoreceptors by immune complexes induces the recruitment of both Src kinases Lyn and Fyn to the receptor leading to full phosphorylation of the tyrosine residues present in the ITAM motif. This leads to the activation and the recruitment of the kinase Syk. In parallel, Fyn initiates a signaling pathway involving a PI3K-PKC\u03b1 axis leading the inactivation of SHP-1 through the phosphorylation of its S591 residue barring its recruitment to the plasma membrane (128). Since S591 phosphorylation on SHP-1 keeps the phosphatase in a closed conformation (127), our recent study showed that the phosphorylation of SHP-1 on S591 residue by Fyn axis renders the Y536 residue inaccessible to Lyn. In agreement, the absence of Fyn favors the phosphorylation of SHP-1 on Y536 by Lyn, despite the crosslinking of Fc\u03b3RIIA (4). These results suggest that the selective absence or inhibition of Fyn may abolish inflammation during auto-immune and proinflammatory diseases. Taken together, inhibition of Fyn or of the molecules which are upstream or downstream this SFK reverses inflammation during auto-immune and inflammatory diseases and thus, could be a new therapeutic strategy to decrease the activating ITAM signaling in these diseases. Along these lines, inhibition of PI3K (a major player of the Fyn-PI3K-PKC\u03b1 axis (4)) prevents RA and lupus nephritis progression in mouse models (129). However, it should be mentioned that since Fyn is essential for activating ITAM signals (i.e., phagocytosis), the inhibition of this SFK may favor infections. Moreover, Fyn plays also other roles independently of FcRs. It has been shown that the absence of Fyn impaired multipolar-bipolar transition of newly generated neurons and neurite formation during the early phase of migration. Additionally, inhibition of Fyn decreased the branching number of the migrating cortical neurons (130). Another important hurdle is that Lyn and Fyn present a high homology and there are currently no selective inhibitory drugs. Therefore, Fyn does not appear as the best target to treat auto-immune and pro-inflammatory diseases. Identification of new targets which are downstream of Fyn and which are expressed specifically by immune cells involved in auto-immune diseases will permit development of new therapeutic strategies for auto-immune diseases that involve FcR.",
            "cite_spans": [
                {
                    "start": 264,
                    "end": 266,
                    "mention": "11",
                    "ref_id": "BIBREF12"
                },
                {
                    "start": 397,
                    "end": 400,
                    "mention": "127",
                    "ref_id": "BIBREF31"
                },
                {
                    "start": 596,
                    "end": 598,
                    "mention": "52",
                    "ref_id": "BIBREF78"
                },
                {
                    "start": 1106,
                    "end": 1109,
                    "mention": "128",
                    "ref_id": "BIBREF32"
                },
                {
                    "start": 1196,
                    "end": 1199,
                    "mention": "127",
                    "ref_id": "BIBREF31"
                },
                {
                    "start": 1456,
                    "end": 1457,
                    "mention": "4",
                    "ref_id": "BIBREF64"
                },
                {
                    "start": 1955,
                    "end": 1956,
                    "mention": "4",
                    "ref_id": "BIBREF64"
                },
                {
                    "start": 2020,
                    "end": 2023,
                    "mention": "129",
                    "ref_id": "BIBREF33"
                },
                {
                    "start": 2510,
                    "end": 2513,
                    "mention": "130",
                    "ref_id": "BIBREF35"
                }
            ],
            "section": "Other Future Strategies to Target FcR-Effectors to Treat Auto-Immune/Inflammatory Diseases ::: Targeting of Fc Receptors as Therapeutic Approaches",
            "ref_spans": []
        },
        {
            "text": "Fc receptors may be responsible for diseases when dysregulated in spite of their physiologic protective function. Unraveling all aspects (expression, function, regulation) of FcR biology should help to define approaches to correct the first and to wield the second to restore homeostasis thus representing new hopes for innovative anti-inflammatory strategies. Progress in these two aspects is currently well underway, already proposing new potent therapeutic tools. The future in this field is a promise of scientific excitement.",
            "cite_spans": [],
            "section": "Conclusion",
            "ref_spans": []
        },
        {
            "text": "The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.",
            "cite_spans": [],
            "section": "Conflict of Interest Statement ::: Author Contributions",
            "ref_spans": []
        }
    ],
    "ref_entries": {
        "TABREF0": {
            "text": "Table 1: Human FcRs: their expression, function and allotypes.\nFrom left to right columns: names, function, alleles that include amino acid variations in immunoglobulin domains and the transmembrane domain, cellular expression of FcRs, and diseases linked to alleles and CNVs (reference numbers are shown), and binding abilities of IgG subclasses to each FcR allele. IgAN, IgA nephropathy; CLL, chronic lymphocytic Leukemia; FcRn, neonatal Fc receptor; AIDS, acquired immune deficiency syndrome; PIgR, Polymeric immunoglobulin receptor; DCs, dendritic cells.",
            "type": "table"
        },
        "FIGREF0": {
            "text": "Figure 1: FcR signaling (e.g., Fc\u03b3RII). (Left), the aggregation by an immune complex of FcR bearing ITAM motif (e.g. Fc\u03b3RIIA) induces phosphorylation of the two ITAM tyrosine residues by Src kinases Lyn and Fyn responsible for recruitment and phosphorylation of Syk inducing cellular activation through PLC\u03b3 and PI3K signaling pathways. The PLC\u03b3 converts PI(4,5)P2 into IP3 and DAG. IP3, a soluble inositol phosphate, leads to Ca2+ mobilization while DAG activate MAPK.PI3K converts PI(4,5)P2 to PI(3,4,5)P3 allowing recruitment of signal intermediates through their pleckstrin homology (PH) domain (Middle), co-ligation between an activating heterologous receptor (e.g., the BCR) and the inhibitory FcR (i.e., Fc\u03b3RIIB) induces phosphorylation of the tyrosine present within the ITIM motif by Lyn (5), leading to the phosphorylation and recruitment of phosphatases (SHIP or SHP). The phosphatases PTEN and SHIP1/2 regulate cellular levels of PI(3,4,5)P3 by hydrolyzing it to PI(4,5)P2 and PI(3,4)P2, respectively. These dephosphorylations inhibit cell proliferation. (Right), monovalent targeting of FcR bearing ITAM motif (e.g., Fc\u03b3RIIA) induces the phosphorylation of the last tyrosine residue of the ITAM motif by Lyn responsible for transient recruitment of Syk followed by that of SHP-1 which abrogates the activation signal.",
            "type": "figure"
        },
        "FIGREF1": {
            "text": "Figure 2: Organization and conformational rearrangements of the IgE Fc. (left), IgE and the binding sites to Fc\u03b5RI (green) and to CD23 (pink) [adapted from Pennington et al. (24)] (Middle and Right). Representation of the open and closed conformations, respectively, of the IgE Fc C\u03b53\u20134 domains, and the mutual allosteric inhibition by Fc\u03b5RI\u03b1 (green) and CD23 (pink).",
            "type": "figure"
        },
        "FIGREF2": {
            "text": "Figure 3: Human type I and II Fc receptors. Schematic representation of human Fc receptors at the cell membrane and their association or not with the FcR\u03b3-chain dimer and the Fc\u03b5RI\u03b2 chain, red circles represent the tyrosine residues. The Fc\u03b3RIIIB is anchored into the outer leaflet of the plasma membrane by a phosphatidylinositol-glycan (green circle).",
            "type": "figure"
        }
    },
    "back_matter": [],
    "bib_entries": {
        "BIBREF0": {
            "title": "Type I and type II Fc receptors regulate innate and adaptive immunity",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Pincetic",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Bournazos",
                    "suffix": ""
                },
                {
                    "first": "DJ",
                    "middle": [],
                    "last": "DiLillo",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Maamary",
                    "suffix": ""
                },
                {
                    "first": "TT",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Dahan",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "Nat Immunol",
            "volume": "15",
            "issn": "",
            "pages": "707-16",
            "other_ids": {
                "DOI": [
                    "10.1038/ni.2939"
                ]
            }
        },
        "BIBREF1": {
            "title": "IgG1 and IVIg induce inhibitory ITAM signaling through FcgammaRIII controlling inflammatory responses",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Aloulou",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Ben Mkaddem",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Biarnes-Pelicot",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Boussetta",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Souchet",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Rossato",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Blood",
            "volume": "119",
            "issn": "",
            "pages": "3084-96",
            "other_ids": {
                "DOI": [
                    "10.1182/blood-2011-08-376046"
                ]
            }
        },
        "BIBREF2": {
            "title": "The IgA1 immune complex-mediated activation of the MAPK/ERK kinase pathway in mesangial cells is associated with glomerular damage in IgA nephropathy",
            "authors": [
                {
                    "first": "H",
                    "middle": [],
                    "last": "Tamouza",
                    "suffix": ""
                },
                {
                    "first": "JM",
                    "middle": [],
                    "last": "Chemouny",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Raskova Kafkova",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Berthelot",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Flamant",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Demion",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Kidney Int",
            "volume": "82",
            "issn": "",
            "pages": "1284-96",
            "other_ids": {
                "DOI": [
                    "10.1038/ki.2012.192"
                ]
            }
        },
        "BIBREF3": {
            "title": "Polymeric IgA1 controls erythroblast proliferation and accelerates erythropoiesis recovery in anemia",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Coulon",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Dussiot",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Grapton",
                    "suffix": ""
                },
                {
                    "first": "TT",
                    "middle": [],
                    "last": "Maciel",
                    "suffix": ""
                },
                {
                    "first": "PH",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Callens",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "Nat Med",
            "volume": "17",
            "issn": "",
            "pages": "1456-65",
            "other_ids": {
                "DOI": [
                    "10.1038/nm.2462"
                ]
            }
        },
        "BIBREF4": {
            "title": "Fc alpha receptor I activation induces leukocyte recruitment and promotes aggravation of glomerulonephritis through the FcR gamma adaptor",
            "authors": [
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Kanamaru",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Arcos-Fajardo",
                    "suffix": ""
                },
                {
                    "first": "IC",
                    "middle": [],
                    "last": "Moura",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Tsuge",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Cohen",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Essig",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Eur J Immunol",
            "volume": "37",
            "issn": "",
            "pages": "1116-28",
            "other_ids": {
                "DOI": [
                    "10.1002/eji.200636826"
                ]
            }
        },
        "BIBREF5": {
            "title": "Alternative endocytic pathway for immunoglobulin A Fc receptors (CD89) depends on the lack of FcRgamma association and protects against degradation of bound ligand",
            "authors": [
                {
                    "first": "P",
                    "middle": [],
                    "last": "Launay",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Patry",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Lehuen",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Pasquier",
                    "suffix": ""
                },
                {
                    "first": "U",
                    "middle": [],
                    "last": "Blank",
                    "suffix": ""
                },
                {
                    "first": "RC",
                    "middle": [],
                    "last": "Monteiro",
                    "suffix": ""
                }
            ],
            "year": 1999,
            "venue": "J Biol Chem",
            "volume": "274",
            "issn": "",
            "pages": "7216-25",
            "other_ids": {
                "DOI": [
                    "10.1074/jbc.274.11.7216"
                ]
            }
        },
        "BIBREF6": {
            "title": "Enhanced auto-antibody production and Mott cell formation in FcmuR-deficient autoimmune mice",
            "authors": [
                {
                    "first": "K",
                    "middle": [],
                    "last": "Honjo",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Kubagawa",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Suzuki",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Takagi",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Ohno",
                    "suffix": ""
                },
                {
                    "first": "RP",
                    "middle": [],
                    "last": "Bucy",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "Int Immunol",
            "volume": "26",
            "issn": "",
            "pages": "659-72",
            "other_ids": {
                "DOI": [
                    "10.1093/intimm/dxu070"
                ]
            }
        },
        "BIBREF7": {
            "title": "Critical role of the IgM Fc receptor in IgM homeostasis, B-cell survival, and humoral immune responses",
            "authors": [
                {
                    "first": "R",
                    "middle": [],
                    "last": "Ouchida",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Mori",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Hase",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Takatsu",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Kurosaki",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Tokuhisa",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Proc Natl Acad Sci USA",
            "volume": "109",
            "issn": "",
            "pages": "E2699-706",
            "other_ids": {
                "DOI": [
                    "10.1073/pnas.1210706109"
                ]
            }
        },
        "BIBREF8": {
            "title": "Enhanced levels of both the membrane-bound and soluble forms of IgM Fc receptor (FcmuR) in patients with chronic lymphocytic leukemia",
            "authors": [
                {
                    "first": "FJ",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Kubagawa",
                    "suffix": ""
                },
                {
                    "first": "MK",
                    "middle": [],
                    "last": "McCollum",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Wilson",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Motohashi",
                    "suffix": ""
                },
                {
                    "first": "LF",
                    "middle": [],
                    "last": "Bertoli",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "Blood",
            "volume": "118",
            "issn": "",
            "pages": "4902-9",
            "other_ids": {
                "DOI": [
                    "10.1182/blood-2011-04-350793"
                ]
            }
        },
        "BIBREF9": {
            "title": "Identification of new phosphorylation sites of CD23 in B-cells of patients with chronic lymphocytic leukemia",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Madarova",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Mucha",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Hresko",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Makarova",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Gdovinova",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Szilasiova",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "Leuk Res",
            "volume": "70",
            "issn": "",
            "pages": "25-33",
            "other_ids": {
                "DOI": [
                    "10.1016/j.leukres.2018.05.002"
                ]
            }
        },
        "BIBREF10": {
            "title": "Human neutrophil Fcgamma receptors initiate and play specialized nonredundant roles in antibody-mediated inflammatory diseases",
            "authors": [
                {
                    "first": "N",
                    "middle": [],
                    "last": "Tsuboi",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Asano",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Lauterbach",
                    "suffix": ""
                },
                {
                    "first": "TN",
                    "middle": [],
                    "last": "Mayadas",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Immunity",
            "volume": "28",
            "issn": "",
            "pages": "833-46",
            "other_ids": {
                "DOI": [
                    "10.1016/j.immuni.2008.04.013"
                ]
            }
        },
        "BIBREF11": {
            "title": "Reversal of arthritis by human monomeric IgA through the receptor-mediated SH2 domain-containing phosphatase 1 Inhibitory pathway",
            "authors": [
                {
                    "first": "E",
                    "middle": [],
                    "last": "Rossato",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Ben Mkaddem",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Kanamaru",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Hurtado-Nedelec",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Hayem",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Descatoire",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "Arthritis Rheumatol",
            "volume": "67",
            "issn": "",
            "pages": "1766-77",
            "other_ids": {
                "DOI": [
                    "10.1002/art.39142"
                ]
            }
        },
        "BIBREF12": {
            "title": "Shifting FcgammaRIIA-ITAM from activation to inhibitory configuration ameliorates arthritis",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Ben Mkaddem",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Hayem",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Jonsson",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Rossato",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Boedec",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Boussetta",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "J Clin Invest",
            "volume": "124",
            "issn": "",
            "pages": "3945-59",
            "other_ids": {
                "DOI": [
                    "10.1172/JCI74572"
                ]
            }
        },
        "BIBREF13": {
            "title": "Blocking Fcalpha receptor I on granulocytes prevents tissue damage induced by IgA autoantibodies",
            "authors": [
                {
                    "first": "LP",
                    "middle": [],
                    "last": "van der Steen",
                    "suffix": ""
                },
                {
                    "first": "JE",
                    "middle": [],
                    "last": "Bakema",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Sesarman",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Florea",
                    "suffix": ""
                },
                {
                    "first": "CW",
                    "middle": [],
                    "last": "Tuk",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Kirtschig",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "J Immunol",
            "volume": "189",
            "issn": "",
            "pages": "1594-601",
            "other_ids": {
                "DOI": [
                    "10.4049/jimmunol.1101763"
                ]
            }
        },
        "BIBREF14": {
            "title": "Peptide mimetics of immunoglobulin A (IgA) and FcalphaRI block IgA-induced human neutrophil activation and migration",
            "authors": [
                {
                    "first": "MH",
                    "middle": [],
                    "last": "Heineke",
                    "suffix": ""
                },
                {
                    "first": "LPE",
                    "middle": [],
                    "last": "van der Steen",
                    "suffix": ""
                },
                {
                    "first": "RM",
                    "middle": [],
                    "last": "Korthouwer",
                    "suffix": ""
                },
                {
                    "first": "JJ",
                    "middle": [],
                    "last": "Hage",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Langedijk JP",
                    "suffix": ""
                },
                {
                    "first": "JJ",
                    "middle": [],
                    "last": "Benschop",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "Eur J Immunol",
            "volume": "47",
            "issn": "",
            "pages": "1835-45",
            "other_ids": {
                "DOI": [
                    "10.1002/eji.201646782"
                ]
            }
        },
        "BIBREF15": {
            "title": "IgE inhibition as a therapy for allergic disease",
            "authors": [
                {
                    "first": "PM",
                    "middle": [],
                    "last": "Jardieu",
                    "suffix": ""
                },
                {
                    "first": "RB",
                    "middle": [],
                    "last": "Fick",
                    "suffix": "Jr"
                }
            ],
            "year": 1999,
            "venue": "Int Arch Allergy Immunol",
            "volume": "118",
            "issn": "",
            "pages": "112-5",
            "other_ids": {
                "DOI": [
                    "10.1159/000024043"
                ]
            }
        },
        "BIBREF16": {
            "title": "Treatment of allergic asthma with monoclonal anti-IgE antibody. rhuMAb-E25 Study Group",
            "authors": [
                {
                    "first": "H",
                    "middle": [],
                    "last": "Milgrom",
                    "suffix": ""
                },
                {
                    "first": "RB",
                    "middle": [],
                    "last": "Fick",
                    "suffix": "Jr"
                },
                {
                    "first": "JQ",
                    "middle": [],
                    "last": "Su",
                    "suffix": ""
                },
                {
                    "first": "JD",
                    "middle": [],
                    "last": "Reimann",
                    "suffix": ""
                },
                {
                    "first": "RK",
                    "middle": [],
                    "last": "Bush",
                    "suffix": ""
                },
                {
                    "first": "ML",
                    "middle": [],
                    "last": "Watrous",
                    "suffix": ""
                }
            ],
            "year": 1999,
            "venue": "N Engl J Med",
            "volume": "341",
            "issn": "",
            "pages": "1966-73",
            "other_ids": {
                "DOI": [
                    "10.1056/NEJM199912233412603"
                ]
            }
        },
        "BIBREF17": {
            "title": "Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin",
            "authors": [
                {
                    "first": "MD",
                    "middle": [],
                    "last": "Kazatchkine",
                    "suffix": ""
                },
                {
                    "first": "SV",
                    "middle": [],
                    "last": "Kaveri",
                    "suffix": ""
                }
            ],
            "year": 2001,
            "venue": "N Engl J Med",
            "volume": "345",
            "issn": "",
            "pages": "747-55",
            "other_ids": {
                "DOI": [
                    "10.1056/NEJMra993360"
                ]
            }
        },
        "BIBREF18": {
            "title": "Immunoglobulin replacement therapy in primary and secondary antibody deficiency: the correct clinical approach",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Pecoraro",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Crescenzi",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Granata",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Genovese",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Spadaro",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "Int Immunopharmacol",
            "volume": "52",
            "issn": "",
            "pages": "136-42",
            "other_ids": {
                "DOI": [
                    "10.1016/j.intimp.2017.09.005"
                ]
            }
        },
        "BIBREF19": {
            "title": "Mechanisms of intravenous immunoglobulin action in immune thrombocytopenic purpura",
            "authors": [
                {
                    "first": "F",
                    "middle": [],
                    "last": "Jin",
                    "suffix": ""
                },
                {
                    "first": "JP",
                    "middle": [],
                    "last": "Balthasar",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Hum Immunol",
            "volume": "66",
            "issn": "",
            "pages": "403-10",
            "other_ids": {
                "DOI": [
                    "10.1016/j.humimm.2005.01.029"
                ]
            }
        },
        "BIBREF20": {
            "title": "Infusion of Fc gamma fragments for treatment of children with acute immune thrombocytopenic purpura",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Debre",
                    "suffix": ""
                },
                {
                    "first": "MC",
                    "middle": [],
                    "last": "Bonnet",
                    "suffix": ""
                },
                {
                    "first": "WH",
                    "middle": [],
                    "last": "Fridman",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Carosella",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Philippe",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Reinert",
                    "suffix": ""
                }
            ],
            "year": 1993,
            "venue": "Lancet",
            "volume": "342",
            "issn": "",
            "pages": "945-9",
            "other_ids": {
                "DOI": [
                    "10.1016/0140-6736(93)92000-J"
                ]
            }
        },
        "BIBREF21": {
            "title": "Anti-inflammatory actions of intravenous immunoglobulin",
            "authors": [
                {
                    "first": "F",
                    "middle": [],
                    "last": "Nimmerjahn",
                    "suffix": ""
                },
                {
                    "first": "JV",
                    "middle": [],
                    "last": "Ravetch",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Annu Rev Immunol",
            "volume": "26",
            "issn": "",
            "pages": "513-33",
            "other_ids": {
                "DOI": [
                    "10.1146/annurev.immunol.26.021607.090232"
                ]
            }
        },
        "BIBREF22": {
            "title": "Intravenous immunoglobulin ameliorates ITP via activating Fc gamma receptors on dendritic cells",
            "authors": [
                {
                    "first": "V",
                    "middle": [],
                    "last": "Siragam",
                    "suffix": ""
                },
                {
                    "first": "AR",
                    "middle": [],
                    "last": "Crow",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Brinc",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Song",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Freedman",
                    "suffix": ""
                },
                {
                    "first": "AH",
                    "middle": [],
                    "last": "Lazarus",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Nat Med",
            "volume": "12",
            "issn": "",
            "pages": "688-92",
            "other_ids": {
                "DOI": [
                    "10.1038/nm1416"
                ]
            }
        },
        "BIBREF23": {
            "title": "Leishmania uses mincle to target an inhibitory ITAM signaling pathway in dendritic cells that dampens adaptive immunity to infection",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Iborra",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Martinez-Lopez",
                    "suffix": ""
                },
                {
                    "first": "FJ",
                    "middle": [],
                    "last": "Cueto",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Conde-Garrosa",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Del Fresno",
                    "suffix": ""
                },
                {
                    "first": "HM",
                    "middle": [],
                    "last": "Izquierdo",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Immunity",
            "volume": "45",
            "issn": "",
            "pages": "788-801",
            "other_ids": {
                "DOI": [
                    "10.1016/j.immuni.2016.09.012"
                ]
            }
        },
        "BIBREF24": {
            "title": "Important drug warning: immune globulin intravenous (human) (IGIV) products",
            "authors": [
                {
                    "first": "JS",
                    "middle": [],
                    "last": "Epstein",
                    "suffix": ""
                },
                {
                    "first": "KC",
                    "middle": [],
                    "last": "Zoon",
                    "suffix": ""
                }
            ],
            "year": 2000,
            "venue": "Neonatal Netw",
            "volume": "19",
            "issn": "",
            "pages": "60-2",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF25": {
            "title": "Spontaneous autoimmune disease in Fc(gamma)RIIB-deficient mice results from strain-specific epistasis",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Bolland",
                    "suffix": ""
                },
                {
                    "first": "JV",
                    "middle": [],
                    "last": "Ravetch",
                    "suffix": ""
                }
            ],
            "year": 2000,
            "venue": "Immunity",
            "volume": "13",
            "issn": "",
            "pages": "277-85",
            "other_ids": {
                "DOI": [
                    "10.1016/S1074-7613(00)00027-3"
                ]
            }
        },
        "BIBREF26": {
            "title": "IVIg-mediated amelioration of murine ITP via FcgammaRIIb is not necessarily independent of SHIP-1 and SHP-1 activity",
            "authors": [
                {
                    "first": "E",
                    "middle": [],
                    "last": "van Mirre",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "van Royen",
                    "suffix": ""
                },
                {
                    "first": "CE",
                    "middle": [],
                    "last": "Hack",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "Blood",
            "volume": "103",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1182/blood-2003-11-3933"
                ]
            }
        },
        "BIBREF27": {
            "title": "Monoclonal antibodies capable of discriminating the human inhibitory Fcgamma-receptor IIB (CD32B) from the activating Fcgamma-receptor IIA (CD32A): biochemical, biological and functional characterization",
            "authors": [
                {
                    "first": "MC",
                    "middle": [],
                    "last": "Veri",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Gorlatov",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Burke",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Johnson",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Stavenhagen",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Immunology",
            "volume": "121",
            "issn": "",
            "pages": "392-404",
            "other_ids": {
                "DOI": [
                    "10.1111/j.1365-2567.2007.02588.x"
                ]
            }
        },
        "BIBREF28": {
            "title": "FcgammaRIIb controls bone marrow plasma cell persistence and apoptosis",
            "authors": [
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Xiang",
                    "suffix": ""
                },
                {
                    "first": "AJ",
                    "middle": [],
                    "last": "Cutler",
                    "suffix": ""
                },
                {
                    "first": "RJ",
                    "middle": [],
                    "last": "Brownlie",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Fairfax",
                    "suffix": ""
                },
                {
                    "first": "KE",
                    "middle": [],
                    "last": "Lawlor",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Severinson",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Nat Immunol",
            "volume": "8",
            "issn": "",
            "pages": "419-29",
            "other_ids": {
                "DOI": [
                    "10.1038/ni1440"
                ]
            }
        },
        "BIBREF29": {
            "title": "Engineering the Fc region of immunoglobulin G to modulate in vivo antibody levels",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Vaccaro",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Zhou",
                    "suffix": ""
                },
                {
                    "first": "RJ",
                    "middle": [],
                    "last": "Ober",
                    "suffix": ""
                },
                {
                    "first": "ES",
                    "middle": [],
                    "last": "Ward",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Nat Biotechnol",
            "volume": "23",
            "issn": "",
            "pages": "1283-8",
            "other_ids": {
                "DOI": [
                    "10.1038/nbt1143"
                ]
            }
        },
        "BIBREF30": {
            "title": "Amelioration of experimental autoimmune myasthenia gravis in rats by neonatal FcR blockade",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                },
                {
                    "first": "AM",
                    "middle": [],
                    "last": "Garcia",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Santoro",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "McDonnell",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Dumont",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "J Immunol",
            "volume": "178",
            "issn": "",
            "pages": "5390-8",
            "other_ids": {
                "DOI": [
                    "10.4049/jimmunol.178.8.5390"
                ]
            }
        },
        "BIBREF31": {
            "title": "The role of C-terminal tyrosine phosphorylation in the regulation of SHP-1 explored via expressed protein ligation",
            "authors": [
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Shen",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Lu",
                    "suffix": ""
                },
                {
                    "first": "PA",
                    "middle": [],
                    "last": "Cole",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "J Biol Chem",
            "volume": "278",
            "issn": "",
            "pages": "4668-74",
            "other_ids": {
                "DOI": [
                    "10.1074/jbc.M210028200"
                ]
            }
        },
        "BIBREF32": {
            "title": "Regulation of SHP-1 tyrosine phosphatase in human platelets by serine phosphorylation at its C terminus",
            "authors": [
                {
                    "first": "ML",
                    "middle": [],
                    "last": "Jones",
                    "suffix": ""
                },
                {
                    "first": "JD",
                    "middle": [],
                    "last": "Craik",
                    "suffix": ""
                },
                {
                    "first": "JM",
                    "middle": [],
                    "last": "Gibbins",
                    "suffix": ""
                },
                {
                    "first": "AW",
                    "middle": [],
                    "last": "Poole",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "J Biol Chem",
            "volume": "279",
            "issn": "",
            "pages": "40475-83",
            "other_ids": {
                "DOI": [
                    "10.1074/jbc.M402970200"
                ]
            }
        },
        "BIBREF33": {
            "title": "Blockade of PI3Kgamma suppresses joint inflammation and damage in mouse models of rheumatoid arthritis",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Camps",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Ruckle",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Ji",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Ardissone",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Rintelen",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Shaw",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Nat Med",
            "volume": "11",
            "issn": "",
            "pages": "936-43",
            "other_ids": {
                "DOI": [
                    "10.1038/nm1284"
                ]
            }
        },
        "BIBREF34": {
            "title": "Of ITIMs, ITAMs, and ITAMis: revisiting immunoglobulin Fc receptor signaling",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Getahun",
                    "suffix": ""
                },
                {
                    "first": "JC",
                    "middle": [],
                    "last": "Cambier",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "Immunol Rev",
            "volume": "268",
            "issn": "",
            "pages": "66-73",
            "other_ids": {
                "DOI": [
                    "10.1111/imr.12336"
                ]
            }
        },
        "BIBREF35": {
            "title": "Fyn regulates multipolar-bipolar transition and neurite morphogenesis of migrating neurons in the developing neocortex",
            "authors": [
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Huang",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "An",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Fan",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Cheng",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "Neuroscience",
            "volume": "352",
            "issn": "",
            "pages": "39-51",
            "other_ids": {
                "DOI": [
                    "10.1016/j.neuroscience.2017.03.032"
                ]
            }
        },
        "BIBREF36": {
            "title": "Inhibitory ITAMs as novel regulators of immunity",
            "authors": [
                {
                    "first": "U",
                    "middle": [],
                    "last": "Blank",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Launay",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Benhamou",
                    "suffix": ""
                },
                {
                    "first": "RC",
                    "middle": [],
                    "last": "Monteiro",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "Immunol Rev",
            "volume": "232",
            "issn": "",
            "pages": "59-71",
            "other_ids": {
                "DOI": [
                    "10.1111/j.1600-065X.2009.00832.x"
                ]
            }
        },
        "BIBREF37": {
            "title": "TCR ligand discrimination is enforced by competing ERK positive and SHP-1 negative feedback pathways",
            "authors": [
                {
                    "first": "I",
                    "middle": [],
                    "last": "Stefanova",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Hemmer",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Vergelli",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Martin",
                    "suffix": ""
                },
                {
                    "first": "WE",
                    "middle": [],
                    "last": "Biddison",
                    "suffix": ""
                },
                {
                    "first": "RN",
                    "middle": [],
                    "last": "Germain",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Nat Immunol",
            "volume": "4",
            "issn": "",
            "pages": "248-54",
            "other_ids": {
                "DOI": [
                    "10.1038/ni895"
                ]
            }
        },
        "BIBREF38": {
            "title": "Continuous inhibitory signaling by both SHP-1 and SHIP-1 pathways is required to maintain unresponsiveness of anergic B cells",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Getahun",
                    "suffix": ""
                },
                {
                    "first": "NA",
                    "middle": [],
                    "last": "Beavers",
                    "suffix": ""
                },
                {
                    "first": "SR",
                    "middle": [],
                    "last": "Larson",
                    "suffix": ""
                },
                {
                    "first": "MJ",
                    "middle": [],
                    "last": "Shlomchik",
                    "suffix": ""
                },
                {
                    "first": "JC",
                    "middle": [],
                    "last": "Cambier",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "J Exp Med",
            "volume": "213",
            "issn": "",
            "pages": "751-69",
            "other_ids": {
                "DOI": [
                    "10.1084/jem.20150537"
                ]
            }
        },
        "BIBREF39": {
            "title": "Distinct roles for neutrophils and dendritic cells in inflammation and autoimmunity in motheaten mice",
            "authors": [
                {
                    "first": "CL",
                    "middle": [],
                    "last": "Abram",
                    "suffix": ""
                },
                {
                    "first": "GL",
                    "middle": [],
                    "last": "Roberge",
                    "suffix": ""
                },
                {
                    "first": "LI",
                    "middle": [],
                    "last": "Pao",
                    "suffix": ""
                },
                {
                    "first": "BG",
                    "middle": [],
                    "last": "Neel",
                    "suffix": ""
                },
                {
                    "first": "CA",
                    "middle": [],
                    "last": "Lowell",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Immunity",
            "volume": "38",
            "issn": "",
            "pages": "489-501",
            "other_ids": {
                "DOI": [
                    "10.1016/j.immuni.2013.02.018"
                ]
            }
        },
        "BIBREF40": {
            "title": "Defective negative regulation of antigen receptor signaling in Lyn-deficient B lymphocytes",
            "authors": [
                {
                    "first": "VW",
                    "middle": [],
                    "last": "Chan",
                    "suffix": ""
                },
                {
                    "first": "CA",
                    "middle": [],
                    "last": "Lowell",
                    "suffix": ""
                },
                {
                    "first": "AL",
                    "middle": [],
                    "last": "DeFranco",
                    "suffix": ""
                }
            ],
            "year": 1998,
            "venue": "Curr Biol",
            "volume": "8",
            "issn": "",
            "pages": "545-53",
            "other_ids": {
                "DOI": [
                    "10.1016/S0960-9822(98)70223-4"
                ]
            }
        },
        "BIBREF41": {
            "title": "Src-family kinases: rheostats of immune cell signaling",
            "authors": [
                {
                    "first": "CA",
                    "middle": [],
                    "last": "Lowell",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "Mol Immunol",
            "volume": "41",
            "issn": "",
            "pages": "631-43",
            "other_ids": {
                "DOI": [
                    "10.1016/j.molimm.2004.04.010"
                ]
            }
        },
        "BIBREF42": {
            "title": "Mouse and human FcR effector functions",
            "authors": [
                {
                    "first": "P",
                    "middle": [],
                    "last": "Bruhns",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Jonsson",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "Immunol Rev",
            "volume": "268",
            "issn": "",
            "pages": "25-51",
            "other_ids": {
                "DOI": [
                    "10.1111/imr.12350"
                ]
            }
        },
        "BIBREF43": {
            "title": "The polymeric immunoglobulin receptor. a model protein to study transcytosis",
            "authors": [
                {
                    "first": "G",
                    "middle": [],
                    "last": "Apodaca",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Bomsel",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Arden",
                    "suffix": ""
                },
                {
                    "first": "PP",
                    "middle": [],
                    "last": "Breitfeld",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Tang",
                    "suffix": ""
                },
                {
                    "first": "KE",
                    "middle": [],
                    "last": "Mostov",
                    "suffix": ""
                }
            ],
            "year": 1991,
            "venue": "J Clin Invest",
            "volume": "87",
            "issn": "",
            "pages": "1877-82",
            "other_ids": {
                "DOI": [
                    "10.1172/JCI115211"
                ]
            }
        },
        "BIBREF44": {
            "title": "Gut microbiota utilize immunoglobulin A for mucosal colonization",
            "authors": [
                {
                    "first": "GP",
                    "middle": [],
                    "last": "Donaldson",
                    "suffix": ""
                },
                {
                    "first": "MS",
                    "middle": [],
                    "last": "Ladinsky",
                    "suffix": ""
                },
                {
                    "first": "KB",
                    "middle": [],
                    "last": "Yu",
                    "suffix": ""
                },
                {
                    "first": "JG",
                    "middle": [],
                    "last": "Sanders",
                    "suffix": ""
                },
                {
                    "first": "BB",
                    "middle": [],
                    "last": "Yoo",
                    "suffix": ""
                },
                {
                    "first": "WC",
                    "middle": [],
                    "last": "Chou",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "Science",
            "volume": "360",
            "issn": "",
            "pages": "795-800",
            "other_ids": {
                "DOI": [
                    "10.1126/science.aaq0926"
                ]
            }
        },
        "BIBREF45": {
            "title": "Unusual biochemical features and follicular dendritic cell expression of human Fcalpha/mu receptor",
            "authors": [
                {
                    "first": "K",
                    "middle": [],
                    "last": "Kikuno",
                    "suffix": ""
                },
                {
                    "first": "DW",
                    "middle": [],
                    "last": "Kang",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Tahara",
                    "suffix": ""
                },
                {
                    "first": "I",
                    "middle": [],
                    "last": "Torii",
                    "suffix": ""
                },
                {
                    "first": "HM",
                    "middle": [],
                    "last": "Kubagawa",
                    "suffix": ""
                },
                {
                    "first": "KJ",
                    "middle": [],
                    "last": "Ho",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Eur J Immunol",
            "volume": "37",
            "issn": "",
            "pages": "3540-50",
            "other_ids": {
                "DOI": [
                    "10.1002/eji.200737655"
                ]
            }
        },
        "BIBREF46": {
            "title": "Structural characterization of anti-inflammatory immunoglobulin G Fc proteins",
            "authors": [
                {
                    "first": "AA",
                    "middle": [],
                    "last": "Ahmed",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Giddens",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Pincetic",
                    "suffix": ""
                },
                {
                    "first": "JV",
                    "middle": [],
                    "last": "Lomino",
                    "suffix": ""
                },
                {
                    "first": "JV",
                    "middle": [],
                    "last": "Ravetch",
                    "suffix": ""
                },
                {
                    "first": "LX",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "J Mol Biol",
            "volume": "426",
            "issn": "",
            "pages": "3166-3179",
            "other_ids": {
                "DOI": [
                    "10.1016/j.jmb.2014.07.006"
                ]
            }
        },
        "BIBREF47": {
            "title": "Structural basis of omalizumab therapy and omalizumab-mediated IgE exchange",
            "authors": [
                {
                    "first": "LF",
                    "middle": [],
                    "last": "Pennington",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Tarchevskaya",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Brigger",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Sathiyamoorthy",
                    "suffix": ""
                },
                {
                    "first": "MT",
                    "middle": [],
                    "last": "Graham",
                    "suffix": ""
                },
                {
                    "first": "KC",
                    "middle": [],
                    "last": "Nadeau",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Nat Commun",
            "volume": "7",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1038/ncomms11610"
                ]
            }
        },
        "BIBREF48": {
            "title": "Fc receptors are major mediators of antibody based inflammation in autoimmunity",
            "authors": [
                {
                    "first": "PM",
                    "middle": [],
                    "last": "Hogarth",
                    "suffix": ""
                }
            ],
            "year": 2002,
            "venue": "Curr Opin Immunol",
            "volume": "14",
            "issn": "",
            "pages": "798-802",
            "other_ids": {
                "DOI": [
                    "10.1016/S0952-7915(02)00409-0"
                ]
            }
        },
        "BIBREF49": {
            "title": "IgA Fc receptors",
            "authors": [
                {
                    "first": "RC",
                    "middle": [],
                    "last": "Monteiro",
                    "suffix": ""
                },
                {
                    "first": "JG",
                    "middle": [],
                    "last": "Van De Winkel",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Annu Rev Immunol",
            "volume": "21",
            "issn": "",
            "pages": "177-204",
            "other_ids": {
                "DOI": [
                    "10.1146/annurev.immunol.21.120601.141011"
                ]
            }
        },
        "BIBREF50": {
            "title": "Identity of the elusive IgM Fc receptor (FcmuR) in humans",
            "authors": [
                {
                    "first": "H",
                    "middle": [],
                    "last": "Kubagawa",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Oka",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Kubagawa",
                    "suffix": ""
                },
                {
                    "first": "I",
                    "middle": [],
                    "last": "Torii",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Takayama",
                    "suffix": ""
                },
                {
                    "first": "DW",
                    "middle": [],
                    "last": "Kang",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "J Exp Med",
            "volume": "206",
            "issn": "",
            "pages": "2779-93",
            "other_ids": {
                "DOI": [
                    "10.1084/jem.20091107"
                ]
            }
        },
        "BIBREF51": {
            "title": "Fc alpha/mu receptor mediates endocytosis of IgM-coated microbes",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Shibuya",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Sakamoto",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Shimizu",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Shibuya",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Osawa",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Hiroyama",
                    "suffix": ""
                }
            ],
            "year": 2000,
            "venue": "Nat Immunol",
            "volume": "1",
            "issn": "",
            "pages": "441-6",
            "other_ids": {
                "DOI": [
                    "10.1038/80886"
                ]
            }
        },
        "BIBREF52": {
            "title": "Fc receptors as adaptive immunoreceptors",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Daeron",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "Curr Top Microbiol Immunol",
            "volume": "382",
            "issn": "",
            "pages": "131-64",
            "other_ids": {
                "DOI": [
                    "10.1007/978-3-319-07911-0_7"
                ]
            }
        },
        "BIBREF53": {
            "title": "The old but new IgM Fc receptor (FcmuR)",
            "authors": [
                {
                    "first": "H",
                    "middle": [],
                    "last": "Kubagawa",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Kubagawa",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Jones",
                    "suffix": ""
                },
                {
                    "first": "TH",
                    "middle": [],
                    "last": "Nasti",
                    "suffix": ""
                },
                {
                    "first": "MR",
                    "middle": [],
                    "last": "Walter",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Honjo",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "Curr Top Microbiol Immunol",
            "volume": "382",
            "issn": "",
            "pages": "3-28",
            "other_ids": {
                "DOI": [
                    "10.1007/978-3-319-07911-0_1"
                ]
            }
        },
        "BIBREF54": {
            "title": "Secretory IgA induces tolerogenic dendritic cells through SIGNR1 dampening autoimmunity in mice",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Diana",
                    "suffix": ""
                },
                {
                    "first": "IC",
                    "middle": [],
                    "last": "Moura",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Vaugier",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Gestin",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Tissandie",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Beaudoin",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "J Immunol",
            "volume": "191",
            "issn": "",
            "pages": "2335-43",
            "other_ids": {
                "DOI": [
                    "10.4049/jimmunol.1300864"
                ]
            }
        },
        "BIBREF55": {
            "title": "Ligation of CD23 triggers cAMP generation and release of inflammatory mediators in human monocytes",
            "authors": [
                {
                    "first": "N",
                    "middle": [],
                    "last": "Paul-Eugene",
                    "suffix": ""
                },
                {
                    "first": "JP",
                    "middle": [],
                    "last": "Kolb",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Abadie",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Gordon",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Delespesse",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Sarfati",
                    "suffix": ""
                }
            ],
            "year": 1992,
            "venue": "J Immunol",
            "volume": "149",
            "issn": "",
            "pages": "3066-71",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF56": {
            "title": "Ligation of CD23 triggers cyclic AMP generation in human B lymphocytes",
            "authors": [
                {
                    "first": "JP",
                    "middle": [],
                    "last": "Kolb",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Abadie",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Paul-Eugene",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Capron",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Sarfati",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Dugas",
                    "suffix": ""
                }
            ],
            "year": 1993,
            "venue": "J Immunol",
            "volume": "150",
            "issn": "",
            "pages": "4798-809",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF57": {
            "title": "CD23-mediated cell signaling in human B cells differs from signaling in cells of the monocytic lineage",
            "authors": [
                {
                    "first": "MA",
                    "middle": [],
                    "last": "Chan",
                    "suffix": ""
                },
                {
                    "first": "NM",
                    "middle": [],
                    "last": "Gigliotti",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Matangkasombut",
                    "suffix": ""
                },
                {
                    "first": "SB",
                    "middle": [],
                    "last": "Gauld",
                    "suffix": ""
                },
                {
                    "first": "JC",
                    "middle": [],
                    "last": "Cambier",
                    "suffix": ""
                },
                {
                    "first": "LJ",
                    "middle": [],
                    "last": "Rosenwasser",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Clin Immunol",
            "volume": "137",
            "issn": "",
            "pages": "330-6",
            "other_ids": {
                "DOI": [
                    "10.1016/j.clim.2010.08.005"
                ]
            }
        },
        "BIBREF58": {
            "title": "Fcgamma receptors: genetic variation, function, and disease",
            "authors": [
                {
                    "first": "CE",
                    "middle": [],
                    "last": "Hargreaves",
                    "suffix": ""
                },
                {
                    "first": "MJ",
                    "middle": [],
                    "last": "Rose-Zerilli",
                    "suffix": ""
                },
                {
                    "first": "LR",
                    "middle": [],
                    "last": "Machado",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Iriyama",
                    "suffix": ""
                },
                {
                    "first": "EJ",
                    "middle": [],
                    "last": "Hollox",
                    "suffix": ""
                },
                {
                    "first": "MS",
                    "middle": [],
                    "last": "Cragg",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "Immunol Rev",
            "volume": "268",
            "issn": "",
            "pages": "6-24",
            "other_ids": {
                "DOI": [
                    "10.1111/imr.12341"
                ]
            }
        },
        "BIBREF59": {
            "title": "Contribution of human fcgammars to disease with evidence from human polymorphisms and transgenic animal studies",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Gillis",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Gouel-Cheron",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Jonsson",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Bruhns",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "Front Immunol",
            "volume": "5",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.3389/fimmu.2014.00254"
                ]
            }
        },
        "BIBREF60": {
            "title": "Human FcR polymorphism and disease",
            "authors": [
                {
                    "first": "X",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "AW",
                    "middle": [],
                    "last": "Gibson",
                    "suffix": ""
                },
                {
                    "first": "RP",
                    "middle": [],
                    "last": "Kimberly",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "Curr Top Microbiol Immunol",
            "volume": "382",
            "issn": "",
            "pages": "275-302",
            "other_ids": {
                "DOI": [
                    "10.1007/978-3-319-07911-0_13"
                ]
            }
        },
        "BIBREF61": {
            "title": "Copy number variation of FCGR3A rather than FCGR3B and FCGR2B is associated with susceptibility to anti-GBM disease",
            "authors": [
                {
                    "first": "XJ",
                    "middle": [],
                    "last": "Zhou",
                    "suffix": ""
                },
                {
                    "first": "JC",
                    "middle": [],
                    "last": "Lv",
                    "suffix": ""
                },
                {
                    "first": "DF",
                    "middle": [],
                    "last": "Bu",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Yu",
                    "suffix": ""
                },
                {
                    "first": "YR",
                    "middle": [],
                    "last": "Yang",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Zhao",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Int Immunol",
            "volume": "22",
            "issn": "",
            "pages": "45-51",
            "other_ids": {
                "DOI": [
                    "10.1093/intimm/dxp113"
                ]
            }
        },
        "BIBREF62": {
            "title": "FCGR3B copy number variation is associated with susceptibility to systemic, but not organ-specific, autoimmunity",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Fanciulli",
                    "suffix": ""
                },
                {
                    "first": "PJ",
                    "middle": [],
                    "last": "Norsworthy",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Petretto",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Dong",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Harper",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Kamesh",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Nat Genet",
            "volume": "39",
            "issn": "",
            "pages": "721-3",
            "other_ids": {
                "DOI": [
                    "10.1038/ng2046"
                ]
            }
        },
        "BIBREF63": {
            "title": "Roles of Fc receptors in autoimmunity",
            "authors": [
                {
                    "first": "T",
                    "middle": [],
                    "last": "Takai",
                    "suffix": ""
                }
            ],
            "year": 2002,
            "venue": "Nat Rev Immunol",
            "volume": "2",
            "issn": "",
            "pages": "580-92",
            "other_ids": {
                "DOI": [
                    "10.1038/nri856"
                ]
            }
        },
        "BIBREF64": {
            "title": "Lyn and Fyn function as molecular switches that control immunoreceptors to direct homeostasis or inflammation",
            "authors": [
                {
                    "first": "SB",
                    "middle": [],
                    "last": "Mkaddem",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Murua",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Flament",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Titeca-Beauport",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Bounaix",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Danelli",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "Nat Commun",
            "volume": "8",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1038/s41467-017-00294-0"
                ]
            }
        },
        "BIBREF65": {
            "title": "Specificity and affinity of human Fcgamma receptors and their polymorphic variants for human IgG subclasses",
            "authors": [
                {
                    "first": "P",
                    "middle": [],
                    "last": "Bruhns",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Iannascoli",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "England",
                    "suffix": ""
                },
                {
                    "first": "DA",
                    "middle": [],
                    "last": "Mancardi",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Fernandez",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Jorieux",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "Blood",
            "volume": "113",
            "issn": "",
            "pages": "3716-25",
            "other_ids": {
                "DOI": [
                    "10.1182/blood-2008-09-179754"
                ]
            }
        },
        "BIBREF66": {
            "title": "Human immunoglobulin G (IgG) Fc receptor IIA (CD32) polymorphism and IgG2-mediated bacterial phagocytosis by neutrophils",
            "authors": [
                {
                    "first": "LA",
                    "middle": [],
                    "last": "Sanders",
                    "suffix": ""
                },
                {
                    "first": "RG",
                    "middle": [],
                    "last": "Feldman",
                    "suffix": ""
                },
                {
                    "first": "MM",
                    "middle": [],
                    "last": "Voorhorst-Ogink",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "de Haas",
                    "suffix": ""
                },
                {
                    "first": "GT",
                    "middle": [],
                    "last": "Rijkers",
                    "suffix": ""
                },
                {
                    "first": "PJ",
                    "middle": [],
                    "last": "Capel",
                    "suffix": ""
                }
            ],
            "year": 1995,
            "venue": "Infect Immun",
            "volume": "63",
            "issn": "",
            "pages": "73-81",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF67": {
            "title": "Fcgamma receptor gene polymorphisms in Japanese patients with systemic lupus erythematosus: contribution of FCGR2B to genetic susceptibility",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Kyogoku",
                    "suffix": ""
                },
                {
                    "first": "HM",
                    "middle": [],
                    "last": "Dijstelbloem",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Tsuchiya",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Hatta",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Kato",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Yamaguchi",
                    "suffix": ""
                }
            ],
            "year": 2002,
            "venue": "Arthritis Rheum",
            "volume": "46",
            "issn": "",
            "pages": "1242-54",
            "other_ids": {
                "DOI": [
                    "10.1002/art.10257"
                ]
            }
        },
        "BIBREF68": {
            "title": "Japan kawasaki disease genome U. S. K. Consortium DG. A genome-wide association study identifies three new risk loci for Kawasaki disease",
            "authors": [
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Onouchi",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Ozaki",
                    "suffix": ""
                },
                {
                    "first": "JC",
                    "middle": [],
                    "last": "Burns",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Shimizu",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Terai",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Hamada",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Nat Genet",
            "volume": "44",
            "issn": "",
            "pages": "517-21",
            "other_ids": {
                "DOI": [
                    "10.1038/ng.2220"
                ]
            }
        },
        "BIBREF69": {
            "title": "A genome-wide association study identifies three new susceptibility loci for ulcerative colitis in the Japanese population",
            "authors": [
                {
                    "first": "K",
                    "middle": [],
                    "last": "Asano",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Matsushita",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Umeno",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Hosono",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Takahashi",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Kawaguchi",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "Nat Genet",
            "volume": "41",
            "issn": "",
            "pages": "1325-9",
            "other_ids": {
                "DOI": [
                    "10.1038/ng.482"
                ]
            }
        },
        "BIBREF70": {
            "title": "IgG receptor IIa alleles determine susceptibility and severity of Guillain-Barre syndrome",
            "authors": [
                {
                    "first": "WL",
                    "middle": [],
                    "last": "van der Pol",
                    "suffix": ""
                },
                {
                    "first": "LH",
                    "middle": [],
                    "last": "van den Berg",
                    "suffix": ""
                },
                {
                    "first": "RH",
                    "middle": [],
                    "last": "Scheepers",
                    "suffix": ""
                },
                {
                    "first": "JG",
                    "middle": [],
                    "last": "van der Bom",
                    "suffix": ""
                },
                {
                    "first": "PA",
                    "middle": [],
                    "last": "van Doorn",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "van Koningsveld",
                    "suffix": ""
                }
            ],
            "year": 2000,
            "venue": "Neurology",
            "volume": "54",
            "issn": "",
            "pages": "1661-5",
            "other_ids": {
                "DOI": [
                    "10.1212/WNL.54.8.1661"
                ]
            }
        },
        "BIBREF71": {
            "title": "Fc-gamma receptor polymorphisms differentially influence susceptibility to systemic lupus erythematosus and lupus nephritis",
            "authors": [
                {
                    "first": "ASMW",
                    "middle": [],
                    "last": "Tsang",
                    "suffix": ""
                },
                {
                    "first": "SQ",
                    "middle": [],
                    "last": "Nagelkerke",
                    "suffix": ""
                },
                {
                    "first": "IE",
                    "middle": [],
                    "last": "Bultink",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Geissler",
                    "suffix": ""
                },
                {
                    "first": "MW",
                    "middle": [],
                    "last": "Tanck",
                    "suffix": ""
                },
                {
                    "first": "CE",
                    "middle": [],
                    "last": "Tacke",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Rheumatology (Oxford)",
            "volume": "55",
            "issn": "",
            "pages": "939-48",
            "other_ids": {
                "DOI": [
                    "10.1093/rheumatology/kev433"
                ]
            }
        },
        "BIBREF72": {
            "title": "The platelet Fc receptor, FcgammaRIIa",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Qiao",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Al-Tamimi",
                    "suffix": ""
                },
                {
                    "first": "RI",
                    "middle": [],
                    "last": "Baker",
                    "suffix": ""
                },
                {
                    "first": "RK",
                    "middle": [],
                    "last": "Andrews",
                    "suffix": ""
                },
                {
                    "first": "EE",
                    "middle": [],
                    "last": "Gardiner",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "Immunol Rev",
            "volume": "268",
            "issn": "",
            "pages": "241-52",
            "other_ids": {
                "DOI": [
                    "10.1111/imr.12370"
                ]
            }
        },
        "BIBREF73": {
            "title": "FcgammaRIIa-131R allele and FcgammaRIIIa-176V/V genotype are risk factors for progression of IgA nephropathy",
            "authors": [
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Tanaka",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Suzuki",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Tsuge",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Kanamaru",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Horikoshi",
                    "suffix": ""
                },
                {
                    "first": "RC",
                    "middle": [],
                    "last": "Monteiro",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Nephrol Dial Transplant",
            "volume": "20",
            "issn": "",
            "pages": "2439-45",
            "other_ids": {
                "DOI": [
                    "10.1093/ndt/gfi043"
                ]
            }
        },
        "BIBREF74": {
            "title": "The role of the human Fc receptor Fc gamma RIIA in the immune clearance of platelets: a transgenic mouse model",
            "authors": [
                {
                    "first": "SE",
                    "middle": [],
                    "last": "McKenzie",
                    "suffix": ""
                },
                {
                    "first": "SM",
                    "middle": [],
                    "last": "Taylor",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Malladi",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Yuhan",
                    "suffix": ""
                },
                {
                    "first": "DL",
                    "middle": [],
                    "last": "Cassel",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Chien",
                    "suffix": ""
                }
            ],
            "year": 1999,
            "venue": "J Immunol",
            "volume": "162",
            "issn": "",
            "pages": "4311-8",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF75": {
            "title": "Fc epsilon receptor I-associated lyn-dependent phosphorylation of Fc gamma receptor IIB during negative regulation of mast cell activation",
            "authors": [
                {
                    "first": "O",
                    "middle": [],
                    "last": "Malbec",
                    "suffix": ""
                },
                {
                    "first": "DC",
                    "middle": [],
                    "last": "Fong",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Turner",
                    "suffix": ""
                },
                {
                    "first": "VL",
                    "middle": [],
                    "last": "Tybulewicz",
                    "suffix": ""
                },
                {
                    "first": "JC",
                    "middle": [],
                    "last": "Cambier",
                    "suffix": ""
                },
                {
                    "first": "WH",
                    "middle": [],
                    "last": "Fridman",
                    "suffix": ""
                }
            ],
            "year": 1998,
            "venue": "J Immunol",
            "volume": "160",
            "issn": "",
            "pages": "1647-58",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF76": {
            "title": "Development of spontaneous multisystem autoimmune disease and hypersensitivity to antibody-induced inflammation in Fcgamma receptor IIa-transgenic mice",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Tan Sardjono",
                    "suffix": ""
                },
                {
                    "first": "PL",
                    "middle": [],
                    "last": "Mottram",
                    "suffix": ""
                },
                {
                    "first": "NC",
                    "middle": [],
                    "last": "van de Velde",
                    "suffix": ""
                },
                {
                    "first": "MS",
                    "middle": [],
                    "last": "Powell",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Power",
                    "suffix": ""
                },
                {
                    "first": "RF",
                    "middle": [],
                    "last": "Slocombe",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Arthritis Rheum",
            "volume": "52",
            "issn": "",
            "pages": "3220-9",
            "other_ids": {
                "DOI": [
                    "10.1002/art.21344"
                ]
            }
        },
        "BIBREF77": {
            "title": "Genetic diversity in human Fc receptor II for immunoglobulin G: Fc gamma receptor IIA ligand-binding polymorphism",
            "authors": [
                {
                    "first": "AF",
                    "middle": [],
                    "last": "Reilly",
                    "suffix": ""
                },
                {
                    "first": "CF",
                    "middle": [],
                    "last": "Norris",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Surrey",
                    "suffix": ""
                },
                {
                    "first": "FJ",
                    "middle": [],
                    "last": "Bruchak",
                    "suffix": ""
                },
                {
                    "first": "EF",
                    "middle": [],
                    "last": "Rappaport",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Schwartz",
                    "suffix": ""
                }
            ],
            "year": 1994,
            "venue": "Clin Diagn Lab Immunol",
            "volume": "1",
            "issn": "",
            "pages": "640-4",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF78": {
            "title": "Inhibitory ITAM signaling traps activating receptors with the phosphatase SHP-1 to form polarized \u201cinhibisome\u201d clusters",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Pfirsch-Maisonnas",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Aloulou",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Xu",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Claver",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Kanamaru",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Tiwari",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "Sci Signal",
            "volume": "4",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1126/scisignal.2001309"
                ]
            }
        },
        "BIBREF79": {
            "title": "Inhibition of destructive autoimmune arthritis in FcgammaRIIa transgenic mice by small chemical entities",
            "authors": [
                {
                    "first": "GA",
                    "middle": [],
                    "last": "Pietersz",
                    "suffix": ""
                },
                {
                    "first": "PL",
                    "middle": [],
                    "last": "Mottram",
                    "suffix": ""
                },
                {
                    "first": "NC",
                    "middle": [],
                    "last": "van de Velde",
                    "suffix": ""
                },
                {
                    "first": "CT",
                    "middle": [],
                    "last": "Sardjono",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Esparon",
                    "suffix": ""
                },
                {
                    "first": "PA",
                    "middle": [],
                    "last": "Ramsland",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "Immunol Cell Biol",
            "volume": "87",
            "issn": "",
            "pages": "3-12",
            "other_ids": {
                "DOI": [
                    "10.1038/icb.2008.82"
                ]
            }
        },
        "BIBREF80": {
            "title": "FcgammaRIIB as a key determinant of agonistic antibody efficacy",
            "authors": [
                {
                    "first": "AL",
                    "middle": [],
                    "last": "White",
                    "suffix": ""
                },
                {
                    "first": "SA",
                    "middle": [],
                    "last": "Beers",
                    "suffix": ""
                },
                {
                    "first": "MS",
                    "middle": [],
                    "last": "Cragg",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "Curr Top Microbiol Immunol",
            "volume": "382",
            "issn": "",
            "pages": "355-72",
            "other_ids": {
                "DOI": [
                    "10.1007/978-3-319-07911-0_16"
                ]
            }
        },
        "BIBREF81": {
            "title": "Loss of function of a lupus-associated FcgammaRIIb polymorphism through exclusion from lipid rafts",
            "authors": [
                {
                    "first": "RA",
                    "middle": [],
                    "last": "Floto",
                    "suffix": ""
                },
                {
                    "first": "MR",
                    "middle": [],
                    "last": "Clatworthy",
                    "suffix": ""
                },
                {
                    "first": "KR",
                    "middle": [],
                    "last": "Heilbronn",
                    "suffix": ""
                },
                {
                    "first": "DR",
                    "middle": [],
                    "last": "Rosner",
                    "suffix": ""
                },
                {
                    "first": "PA",
                    "middle": [],
                    "last": "MacAry",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Rankin",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Nat Med",
            "volume": "11",
            "issn": "",
            "pages": "1056-8",
            "other_ids": {
                "DOI": [
                    "10.1038/nm1288"
                ]
            }
        },
        "BIBREF82": {
            "title": "FcgammaRIIB and autoimmunity",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Espeli",
                    "suffix": ""
                },
                {
                    "first": "KG",
                    "middle": [],
                    "last": "Smith",
                    "suffix": ""
                },
                {
                    "first": "MR",
                    "middle": [],
                    "last": "Clatworthy",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Immunol Rev",
            "volume": "269",
            "issn": "",
            "pages": "194-211",
            "other_ids": {
                "DOI": [
                    "10.1111/imr.12368"
                ]
            }
        },
        "BIBREF83": {
            "title": "Restoration of tolerance in lupus by targeted inhibitory receptor expression",
            "authors": [
                {
                    "first": "TL",
                    "middle": [],
                    "last": "McGaha",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Sorrentino",
                    "suffix": ""
                },
                {
                    "first": "JV",
                    "middle": [],
                    "last": "Ravetch",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Science",
            "volume": "307",
            "issn": "",
            "pages": "590-3",
            "other_ids": {
                "DOI": [
                    "10.1126/science.1105160"
                ]
            }
        },
        "BIBREF84": {
            "title": "Fcgamma receptor type IIIA is associated with rheumatoid arthritis in two distinct ethnic groups",
            "authors": [
                {
                    "first": "AW",
                    "middle": [],
                    "last": "Morgan",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Griffiths",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Ponchel",
                    "suffix": ""
                },
                {
                    "first": "BM",
                    "middle": [],
                    "last": "Montague",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Ali",
                    "suffix": ""
                },
                {
                    "first": "PP",
                    "middle": [],
                    "last": "Gardner",
                    "suffix": ""
                }
            ],
            "year": 2000,
            "venue": "Arthritis Rheum",
            "volume": "43",
            "issn": "",
            "pages": "2328-34",
            "other_ids": {
                "DOI": [
                    "10.1002/1529-0131(200010)43:10&lt;2328::AID-ANR21&gt;3.0.CO;2-Z"
                ]
            }
        },
        "BIBREF85": {
            "title": "Association of Fcgamma receptor IIIA polymorphism with rheumatoid arthritis: comment on the article by Morgan et al",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Nieto",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Pascual",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Caliz",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Mataran",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Martin",
                    "suffix": ""
                }
            ],
            "year": 2002,
            "venue": "Arthritis Rheum",
            "volume": "46",
            "issn": "",
            "pages": "556-9",
            "other_ids": {
                "DOI": [
                    "10.1002/art.10122"
                ]
            }
        },
        "BIBREF86": {
            "title": "Inhibitory pathways triggered by ITIM-containing receptors",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Bolland",
                    "suffix": ""
                },
                {
                    "first": "JV",
                    "middle": [],
                    "last": "Ravetch",
                    "suffix": ""
                }
            ],
            "year": 1999,
            "venue": "Adv Immunol",
            "volume": "72",
            "issn": "",
            "pages": "149-77",
            "other_ids": {
                "DOI": [
                    "10.1016/S0065-2776(08)60019-X"
                ]
            }
        },
        "BIBREF87": {
            "title": "Polymorphism in promoter region of Fcalpha receptor gene in patients with IgA nephropathy",
            "authors": [
                {
                    "first": "T",
                    "middle": [],
                    "last": "Tsuge",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Shimokawa",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Horikoshi",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Tomino",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Ra",
                    "suffix": ""
                }
            ],
            "year": 2001,
            "venue": "Hum Genet",
            "volume": "108",
            "issn": "",
            "pages": "128-33",
            "other_ids": {
                "DOI": [
                    "10.1007/s004390100458"
                ]
            }
        },
        "BIBREF88": {
            "title": "FcalphaRI (CD89) alleles determine the proinflammatory potential of serum IgA.",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Wu",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Ji",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Xie",
                    "suffix": ""
                },
                {
                    "first": "CD",
                    "middle": [],
                    "last": "Langefeld",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Qian",
                    "suffix": ""
                },
                {
                    "first": "AW",
                    "middle": [],
                    "last": "Gibson",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "J Immunol",
            "volume": "178",
            "issn": "",
            "pages": "3973-82",
            "other_ids": {
                "DOI": [
                    "10.4049/jimmunol.178.6.3973"
                ]
            }
        },
        "BIBREF89": {
            "title": "The functional polymorphism 844 A>G in FcalphaRI (CD89) does not contribute to systemic sclerosis or rheumatoid arthritis susceptibility",
            "authors": [
                {
                    "first": "JC",
                    "middle": [],
                    "last": "Broen",
                    "suffix": ""
                },
                {
                    "first": "MJ",
                    "middle": [],
                    "last": "Coenen",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Rueda",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Witte",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Padyukov",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Klareskog",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "J Rheumatol",
            "volume": "38",
            "issn": "",
            "pages": "446-9",
            "other_ids": {
                "DOI": [
                    "10.3899/jrheum.100427"
                ]
            }
        },
        "BIBREF90": {
            "title": "Single nucleotidic polymorphism 844 A->G of FCAR is not associated with IgA nephropathy in Caucasians",
            "authors": [
                {
                    "first": "N",
                    "middle": [],
                    "last": "Maillard",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Thibaudin",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Abadja",
                    "suffix": ""
                },
                {
                    "first": "I",
                    "middle": [],
                    "last": "Masson",
                    "suffix": ""
                },
                {
                    "first": "O",
                    "middle": [],
                    "last": "Garraud",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Berthoux",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Nephrol Dial Transplant",
            "volume": "27",
            "issn": "",
            "pages": "656-60",
            "other_ids": {
                "DOI": [
                    "10.1093/ndt/gfr246"
                ]
            }
        },
        "BIBREF91": {
            "title": "A novel polymorphism of FcalphaRI (CD89) associated with aggressive periodontitis",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Kaneko",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Kobayashi",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Yamamoto",
                    "suffix": ""
                },
                {
                    "first": "MD",
                    "middle": [],
                    "last": "Jansen",
                    "suffix": ""
                },
                {
                    "first": "JG",
                    "middle": [],
                    "last": "van de Winkel",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Yoshie",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "Tissue Antigens",
            "volume": "63",
            "issn": "",
            "pages": "572-7",
            "other_ids": {
                "DOI": [
                    "10.1111/j.0001-2815.2004.0228.x"
                ]
            }
        },
        "BIBREF92": {
            "title": "Polymeric immunoglobulin receptor polymorphisms and risk of nasopharyngeal cancer",
            "authors": [
                {
                    "first": "R",
                    "middle": [],
                    "last": "Hirunsatit",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Kongruttanachok",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Shotelersuk",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Supiyaphun",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Voravud",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Sakuntabhai",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "BMC Genet",
            "volume": "4",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1186/1471-2156-4-3"
                ]
            }
        },
        "BIBREF93": {
            "title": "A novel\u221266T/C polymorphism in Fc epsilon RI alpha-chain promoter affecting the transcription activity: possible relationship to allergic diseases",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Hasegawa",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Nishiyama",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Nishiyama",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Akizawa",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Mitsuishi",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Ito",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "J Immunol",
            "volume": "171",
            "issn": "",
            "pages": "1927-33",
            "other_ids": {
                "DOI": [
                    "10.4049/jimmunol.171.4.1927"
                ]
            }
        },
        "BIBREF94": {
            "title": "The alpha-chain of high-affinity receptor for IgE (FcepsilonRIalpha) gene polymorphisms and serum IgE levels",
            "authors": [
                {
                    "first": "DP",
                    "middle": [],
                    "last": "Potaczek",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Sanak",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Mastalerz",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Setkowicz",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Kaczor",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Nizankowska",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Allergy",
            "volume": "61",
            "issn": "",
            "pages": "1230-3",
            "other_ids": {
                "DOI": [
                    "10.1111/j.1398-9995.2006.01195.x"
                ]
            }
        },
        "BIBREF95": {
            "title": "Genetic mechanism of aspirin-induced urticaria/angioedema",
            "authors": [
                {
                    "first": "SH",
                    "middle": [],
                    "last": "Kim",
                    "suffix": ""
                },
                {
                    "first": "YM",
                    "middle": [],
                    "last": "Ye",
                    "suffix": ""
                },
                {
                    "first": "SK",
                    "middle": [],
                    "last": "Lee",
                    "suffix": ""
                },
                {
                    "first": "HS",
                    "middle": [],
                    "last": "Park",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Curr Opin Allergy Clin Immunol",
            "volume": "6",
            "issn": "",
            "pages": "266-70",
            "other_ids": {
                "DOI": [
                    "10.1097/01.all.0000235899.57182.d4"
                ]
            }
        },
        "BIBREF96": {
            "title": "Association of polymorphisms in the promoter region of FCER1A gene with atopic dermatitis, chronic uticaria, asthma, and serum immunoglobulin E levels in a Han Chinese population",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Zhou",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Zhou",
                    "suffix": ""
                },
                {
                    "first": "LH",
                    "middle": [],
                    "last": "Lin",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Peng",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Hum Immunol",
            "volume": "73",
            "issn": "",
            "pages": "301-5",
            "other_ids": {
                "DOI": [
                    "10.1016/j.humimm.2011.12.001"
                ]
            }
        },
        "BIBREF97": {
            "title": "Identification of FcalphaRI as an inhibitory receptor that controls inflammation: dual role of FcRgamma ITAM",
            "authors": [
                {
                    "first": "B",
                    "middle": [],
                    "last": "Pasquier",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Launay",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Kanamaru",
                    "suffix": ""
                },
                {
                    "first": "IC",
                    "middle": [],
                    "last": "Moura",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Pfirsch",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Ruffie",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Immunity",
            "volume": "22",
            "issn": "",
            "pages": "31-42",
            "other_ids": {
                "DOI": [
                    "10.1016/j.immuni.2004.11.017"
                ]
            }
        },
        "BIBREF98": {
            "title": "The E237G polymorphism of the high-affinity IgE receptor beta chain and asthma",
            "authors": [
                {
                    "first": "X",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Qiu",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Sandford",
                    "suffix": ""
                },
                {
                    "first": "WC",
                    "middle": [],
                    "last": "Tan",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "Ann Allergy Asthma Immunol",
            "volume": "93",
            "issn": "",
            "pages": "499-503",
            "other_ids": {
                "DOI": [
                    "10.1016/S1081-1206(10)61419-6"
                ]
            }
        },
        "BIBREF99": {
            "title": "Association of the MS4A2 gene promoter C-109T or the 7th exon E237G polymorphisms with asthma risk: a meta-analysis",
            "authors": [
                {
                    "first": "HJ",
                    "middle": [],
                    "last": "Yang",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Zheng",
                    "suffix": ""
                },
                {
                    "first": "XF",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Yang",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Huang",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "Clin Biochem",
            "volume": "47",
            "issn": "",
            "pages": "605-11",
            "other_ids": {
                "DOI": [
                    "10.1016/j.clinbiochem.2014.01.022"
                ]
            }
        },
        "BIBREF100": {
            "title": "Functional Fcgamma receptor polymorphisms are associated with human allergy",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Wu",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Lin",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Huang",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Guan",
                    "suffix": ""
                },
                {
                    "first": "WS",
                    "middle": [],
                    "last": "Oetting",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Sriramarao",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "PLoS ONE",
            "volume": "9",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1371/journal.pone.0089196"
                ]
            }
        },
        "BIBREF101": {
            "title": "Phenotypic variation in IgG receptors by nonclassical FCGR2C alleles",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "van der Heijden",
                    "suffix": ""
                },
                {
                    "first": "WB",
                    "middle": [],
                    "last": "Breunis",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Geissler",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "de Boer",
                    "suffix": ""
                },
                {
                    "first": "TK",
                    "middle": [],
                    "last": "van den Berg",
                    "suffix": ""
                },
                {
                    "first": "TW",
                    "middle": [],
                    "last": "Kuijpers",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "J Immunol",
            "volume": "188",
            "issn": "",
            "pages": "1318-24",
            "other_ids": {
                "DOI": [
                    "10.4049/jimmunol.1003945"
                ]
            }
        },
        "BIBREF102": {
            "title": "Associations between FCGR3A polymorphisms and susceptibility to rheumatoid arthritis: a metaanalysis",
            "authors": [
                {
                    "first": "YH",
                    "middle": [],
                    "last": "Lee",
                    "suffix": ""
                },
                {
                    "first": "JD",
                    "middle": [],
                    "last": "Ji",
                    "suffix": ""
                },
                {
                    "first": "GG",
                    "middle": [],
                    "last": "Song",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "J Rheumatol",
            "volume": "35",
            "issn": "",
            "pages": "2129-35",
            "other_ids": {
                "DOI": [
                    "10.3899/jrheum.080186"
                ]
            }
        },
        "BIBREF103": {
            "title": "Fcgamma receptor IIa and IIIa polymorphisms in childhood immune thrombocytopenic purpura",
            "authors": [
                {
                    "first": "MD",
                    "middle": [],
                    "last": "Carcao",
                    "suffix": ""
                },
                {
                    "first": "VS",
                    "middle": [],
                    "last": "Blanchette",
                    "suffix": ""
                },
                {
                    "first": "CD",
                    "middle": [],
                    "last": "Wakefield",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Stephens",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Ellis",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Matheson",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Br J Haematol",
            "volume": "120",
            "issn": "",
            "pages": "135-41",
            "other_ids": {
                "DOI": [
                    "10.1046/j.1365-2141.2003.04033.x"
                ]
            }
        },
        "BIBREF104": {
            "title": "The Fc gammaRIIIA-158F allele is a risk factor for systemic lupus erythematosus",
            "authors": [
                {
                    "first": "HR",
                    "middle": [],
                    "last": "Koene",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Kleijer",
                    "suffix": ""
                },
                {
                    "first": "AJ",
                    "middle": [],
                    "last": "Swaak",
                    "suffix": ""
                },
                {
                    "first": "KE",
                    "middle": [],
                    "last": "Sullivan",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Bijl",
                    "suffix": ""
                },
                {
                    "first": "MA",
                    "middle": [],
                    "last": "Petri",
                    "suffix": ""
                }
            ],
            "year": 1998,
            "venue": "Arthritis Rheum",
            "volume": "41",
            "issn": "",
            "pages": "1813-8",
            "other_ids": {
                "DOI": [
                    "10.1002/1529-0131(199810)41:10&lt;1813::AID-ART13&gt;3.0.CO;2-6"
                ]
            }
        },
        "BIBREF105": {
            "title": "FCGR3A-158 polymorphism influences the biological response to infliximab in Crohn's disease through affecting the ADCC activity",
            "authors": [
                {
                    "first": "R",
                    "middle": [],
                    "last": "Moroi",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Endo",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Kinouchi",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Shiga",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Kakuta",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Kuroha",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Immunogenetics",
            "volume": "65",
            "issn": "",
            "pages": "265-71",
            "other_ids": {
                "DOI": [
                    "10.1007/s00251-013-0679-8"
                ]
            }
        },
        "BIBREF106": {
            "title": "IgA and IgG antineutrophil cytoplasmic antibody engagement of Fc receptor genetic variants influences granulomatosis with polyangiitis",
            "authors": [
                {
                    "first": "JM",
                    "middle": [],
                    "last": "Kelley",
                    "suffix": ""
                },
                {
                    "first": "PA",
                    "middle": [],
                    "last": "Monach",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Ji",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Zhou",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Wu",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Tanaka",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "Proc Natl Acad Sci U.S.A",
            "volume": "108",
            "issn": "",
            "pages": "20736-41",
            "other_ids": {
                "DOI": [
                    "10.1073/pnas.1109227109"
                ]
            }
        },
        "BIBREF107": {
            "title": "FcalphaRI-positive liver Kupffer cells: reappraisal of the function of immunoglobulin A in immunity",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "van Egmond",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "van Garderen",
                    "suffix": ""
                },
                {
                    "first": "AB",
                    "middle": [],
                    "last": "van Spriel",
                    "suffix": ""
                },
                {
                    "first": "CA",
                    "middle": [],
                    "last": "Damen",
                    "suffix": ""
                },
                {
                    "first": "ES",
                    "middle": [],
                    "last": "van Amersfoort",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "van Zandbergen",
                    "suffix": ""
                }
            ],
            "year": 2000,
            "venue": "Nat Med",
            "volume": "6",
            "issn": "",
            "pages": "680-5",
            "other_ids": {
                "DOI": [
                    "10.1038/76261"
                ]
            }
        },
        "BIBREF108": {
            "title": "CD16 promotes Escherichia coli sepsis through an FcR gamma inhibitory pathway that prevents phagocytosis and facilitates inflammation",
            "authors": [
                {
                    "first": "F",
                    "middle": [],
                    "last": "Pinheiro da Silva",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Aloulou",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Skurnik",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Benhamou",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Andremont",
                    "suffix": ""
                },
                {
                    "first": "IT",
                    "middle": [],
                    "last": "Velasco",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Nat Med",
            "volume": "13",
            "issn": "",
            "pages": "1368-74",
            "other_ids": {
                "DOI": [
                    "10.1038/nm1665"
                ]
            }
        },
        "BIBREF109": {
            "title": "Overexpression of TOSO in CLL is triggered by B-cell receptor signaling and associated with progressive disease",
            "authors": [
                {
                    "first": "CP",
                    "middle": [],
                    "last": "Pallasch",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Schulz",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Kutsch",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Schwamb",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Hagist",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Kashkar",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Blood",
            "volume": "112",
            "issn": "",
            "pages": "4213-9",
            "other_ids": {
                "DOI": [
                    "10.1182/blood-2008-05-157255"
                ]
            }
        },
        "BIBREF110": {
            "title": "Toso, a cell surface, specific regulator of Fas-induced apoptosis in T cells",
            "authors": [
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Hitoshi",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Lorens",
                    "suffix": ""
                },
                {
                    "first": "SI",
                    "middle": [],
                    "last": "Kitada",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Fisher",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "LaBarge",
                    "suffix": ""
                },
                {
                    "first": "HZ",
                    "middle": [],
                    "last": "Ring",
                    "suffix": ""
                }
            ],
            "year": 1998,
            "venue": "Immunity",
            "volume": "8",
            "issn": "",
            "pages": "461-71",
            "other_ids": {
                "DOI": [
                    "10.1016/S1074-7613(00)80551-8"
                ]
            }
        },
        "BIBREF111": {
            "title": "Increased expression of CD23 (Fc(epsilon) receptor II) by peripheral blood monocytes of aids patients",
            "authors": [
                {
                    "first": "LS",
                    "middle": [],
                    "last": "Miller",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Atabai",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Nowakowski",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Chan",
                    "suffix": ""
                },
                {
                    "first": "MH",
                    "middle": [],
                    "last": "Bluth",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Minkoff",
                    "suffix": ""
                }
            ],
            "year": 2001,
            "venue": "AIDS Res Hum Retroviruses",
            "volume": "17",
            "issn": "",
            "pages": "443-52",
            "other_ids": {
                "DOI": [
                    "10.1089/088922201750102544"
                ]
            }
        },
        "BIBREF112": {
            "title": "FcgammaRIIIA-158V and rheumatoid arthritis: a confirmation study",
            "authors": [
                {
                    "first": "AW",
                    "middle": [],
                    "last": "Morgan",
                    "suffix": ""
                },
                {
                    "first": "VH",
                    "middle": [],
                    "last": "Keyte",
                    "suffix": ""
                },
                {
                    "first": "SJ",
                    "middle": [],
                    "last": "Babbage",
                    "suffix": ""
                },
                {
                    "first": "JI",
                    "middle": [],
                    "last": "Robinson",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Ponchel",
                    "suffix": ""
                },
                {
                    "first": "JH",
                    "middle": [],
                    "last": "Barrett",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Rheumatology (Oxford)",
            "volume": "42",
            "issn": "",
            "pages": "528-33",
            "other_ids": {
                "DOI": [
                    "10.1093/rheumatology/keg169"
                ]
            }
        },
        "BIBREF113": {
            "title": "CD32a is a marker of a CD4 T-cell HIV reservoir harbouring replication-competent proviruses",
            "authors": [
                {
                    "first": "B",
                    "middle": [],
                    "last": "Descours",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Petitjean",
                    "suffix": ""
                },
                {
                    "first": "JL",
                    "middle": [],
                    "last": "Lopez-Zaragoza",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Bruel",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Raffel",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Psomas",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "Nature",
            "volume": "543",
            "issn": "",
            "pages": "564-567",
            "other_ids": {
                "DOI": [
                    "10.1038/nature21710"
                ]
            }
        },
        "BIBREF114": {
            "title": "CD32 is expressed on cells with transcriptionally active HIV but does not enrich for HIV DNA in resting T cells",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Abdel-Mohsen",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Kuri-Cervantes",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Grau-Exposito",
                    "suffix": ""
                },
                {
                    "first": "AM",
                    "middle": [],
                    "last": "Spivak",
                    "suffix": ""
                },
                {
                    "first": "RA",
                    "middle": [],
                    "last": "Nell",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Tomescu",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "Sci Transl Med",
            "volume": "10",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1126/scitranslmed.aar6759."
                ]
            }
        },
        "BIBREF115": {
            "title": "CD32 expression is associated to T-cell activation and is not a marker of the HIV-1 reservoir",
            "authors": [
                {
                    "first": "R",
                    "middle": [],
                    "last": "Badia",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Ballana",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Castellvi",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Garcia-Vidal",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Pujantell",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Clotet",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "Nat Commun",
            "volume": "9",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1038/s41467-018-05157-w"
                ]
            }
        },
        "BIBREF116": {
            "title": "Expression profile of FcgammaRIIb on leukocytes and its dysregulation in systemic lupus erythematosus",
            "authors": [
                {
                    "first": "K",
                    "middle": [],
                    "last": "Su",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Yang",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "AW",
                    "middle": [],
                    "last": "Gibson",
                    "suffix": ""
                },
                {
                    "first": "JM",
                    "middle": [],
                    "last": "Cafardi",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "J Immunol",
            "volume": "178",
            "issn": "",
            "pages": "3272-80",
            "other_ids": {
                "DOI": [
                    "10.4049/jimmunol.178.5.3272"
                ]
            }
        },
        "BIBREF117": {
            "title": "CD32b expression is down-regulated on double-negative memory B cells in patients with Hashimoto's thyroiditis",
            "authors": [
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Gong",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Qu",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "You",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Yu",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "Mol Cell Endocrinol",
            "volume": "440",
            "issn": "",
            "pages": "1-7",
            "other_ids": {
                "DOI": [
                    "10.1016/j.mce.2016.11.004"
                ]
            }
        },
        "BIBREF118": {
            "title": "The three human monocyte subsets: implications for health and disease",
            "authors": [
                {
                    "first": "KL",
                    "middle": [],
                    "last": "Wong",
                    "suffix": ""
                },
                {
                    "first": "WH",
                    "middle": [],
                    "last": "Yeap",
                    "suffix": ""
                },
                {
                    "first": "JJ",
                    "middle": [],
                    "last": "Tai",
                    "suffix": ""
                },
                {
                    "first": "SM",
                    "middle": [],
                    "last": "Ong",
                    "suffix": ""
                },
                {
                    "first": "TM",
                    "middle": [],
                    "last": "Dang",
                    "suffix": ""
                },
                {
                    "first": "SC",
                    "middle": [],
                    "last": "Wong",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Immunol Res",
            "volume": "53",
            "issn": "",
            "pages": "41-57",
            "other_ids": {
                "DOI": [
                    "10.1007/s12026-012-8297-3"
                ]
            }
        },
        "BIBREF119": {
            "title": "Inhibitory ITAM signaling by Fc alpha RI-FcR gamma chain controls multiple activating responses and prevents renal inflammation",
            "authors": [
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Kanamaru",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Pfirsch",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Aloulou",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Vrtovsnik",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Essig",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Loirat",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "J Immunol",
            "volume": "180",
            "issn": "",
            "pages": "2669-78",
            "other_ids": {
                "DOI": [
                    "10.4049/jimmunol.180.4.2669"
                ]
            }
        },
        "BIBREF120": {
            "title": "Down-regulation of Fc alpha receptors on blood cells of IgA nephropathy patients: evidence for a negative regulatory role of serum IgA",
            "authors": [
                {
                    "first": "B",
                    "middle": [],
                    "last": "Grossetete",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Launay",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Lehuen",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Jungers",
                    "suffix": ""
                },
                {
                    "first": "JF",
                    "middle": [],
                    "last": "Bach",
                    "suffix": ""
                },
                {
                    "first": "RC",
                    "middle": [],
                    "last": "Monteiro",
                    "suffix": ""
                }
            ],
            "year": 1998,
            "venue": "Kidney Int",
            "volume": "53",
            "issn": "",
            "pages": "1321-35",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF121": {
            "title": "Impaired Fc alpha receptor expression is linked to increased immunoglobulin A levels and disease progression in HIV-1-infected patients",
            "authors": [
                {
                    "first": "B",
                    "middle": [],
                    "last": "Grossetete",
                    "suffix": ""
                },
                {
                    "first": "JP",
                    "middle": [],
                    "last": "Viard",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Lehuen",
                    "suffix": ""
                },
                {
                    "first": "JF",
                    "middle": [],
                    "last": "Bach",
                    "suffix": ""
                },
                {
                    "first": "RC",
                    "middle": [],
                    "last": "Monteiro",
                    "suffix": ""
                }
            ],
            "year": 1995,
            "venue": "AIDS",
            "volume": "9",
            "issn": "",
            "pages": "229-34",
            "other_ids": {
                "DOI": [
                    "10.1097/00002030-199509030-00003"
                ]
            }
        },
        "BIBREF122": {
            "title": "Altered expression of monocyte IgA Fc receptors is associated with defective endocytosis in patients with alcoholic cirrhosis. Potential role for IFN-gamma",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Silvain",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Patry",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Launay",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Lehuen",
                    "suffix": ""
                },
                {
                    "first": "RC",
                    "middle": [],
                    "last": "Monteiro",
                    "suffix": ""
                }
            ],
            "year": 1995,
            "venue": "J Immunol",
            "volume": "155",
            "issn": "",
            "pages": "1606-18",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF123": {
            "title": "Value of biomarkers for predicting immunoglobulin A vasculitis nephritis outcome in an adult prospective cohort",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Berthelot",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Jamin",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Viglietti",
                    "suffix": ""
                },
                {
                    "first": "JM",
                    "middle": [],
                    "last": "Chemouny",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Ayari",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Pierre",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "Nephrol Dial Transplant",
            "volume": "33",
            "issn": "",
            "pages": "1579-90",
            "other_ids": {
                "DOI": [
                    "10.1093/ndt/gfx300"
                ]
            }
        },
        "BIBREF124": {
            "title": "Deglycosylation of FcalphaR at N58 increases its binding to IgA",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Xue",
                    "suffix": ""
                },
                {
                    "first": "Q",
                    "middle": [],
                    "last": "Zhao",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Zhu",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Glycobiology",
            "volume": "20",
            "issn": "",
            "pages": "905-15",
            "other_ids": {
                "DOI": [
                    "10.1093/glycob/cwq048"
                ]
            }
        },
        "BIBREF125": {
            "title": "Recent advances in the physiopathology of IgA nephropathy",
            "authors": [
                {
                    "first": "RC",
                    "middle": [],
                    "last": "Monteiro",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "Nephrol Ther",
            "volume": "14",
            "issn": "Suppl 1",
            "pages": "S1-8",
            "other_ids": {
                "DOI": [
                    "10.1016/j.nephro.2018.02.004"
                ]
            }
        },
        "BIBREF126": {
            "title": "Association of soluble CD89 levels with disease progression but not susceptibility in IgA nephropathy",
            "authors": [
                {
                    "first": "MT",
                    "middle": [],
                    "last": "Vuong",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Hahn-Zoric",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Lundberg",
                    "suffix": ""
                },
                {
                    "first": "I",
                    "middle": [],
                    "last": "Gunnarsson",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "van Kooten",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Wramner",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Kidney Int",
            "volume": "78",
            "issn": "",
            "pages": "1281-7",
            "other_ids": {
                "DOI": [
                    "10.1038/ki.2010.314"
                ]
            }
        },
        "BIBREF127": {
            "title": "Recurrent IgA nephropathy is predicted by altered glycosylated IgA, autoantibodies and soluble CD89 complexes",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Berthelot",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Robert",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Vuiblet",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Tabary",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Braconnier",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Drame",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "Kidney Int",
            "volume": "88",
            "issn": "",
            "pages": "815-22",
            "other_ids": {
                "DOI": [
                    "10.1038/ki.2015.158"
                ]
            }
        },
        "BIBREF128": {
            "title": "Transglutaminase is essential for IgA nephropathy development acting through IgA receptors",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Berthelot",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Papista",
                    "suffix": ""
                },
                {
                    "first": "TT",
                    "middle": [],
                    "last": "Maciel",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Biarnes-Pelicot",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Tissandie",
                    "suffix": ""
                },
                {
                    "first": "PH",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "J Exp Med",
            "volume": "209",
            "issn": "",
            "pages": "793-806",
            "other_ids": {
                "DOI": [
                    "10.1084/jem.20112005"
                ]
            }
        },
        "BIBREF129": {
            "title": "Identification of the transferrin receptor as a novel immunoglobulin (Ig)A1 receptor and its enhanced expression on mesangial cells in IgA nephropathy",
            "authors": [
                {
                    "first": "IC",
                    "middle": [],
                    "last": "Moura",
                    "suffix": ""
                },
                {
                    "first": "MN",
                    "middle": [],
                    "last": "Centelles",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Arcos-Fajardo",
                    "suffix": ""
                },
                {
                    "first": "DM",
                    "middle": [],
                    "last": "Malheiros",
                    "suffix": ""
                },
                {
                    "first": "JF",
                    "middle": [],
                    "last": "Collawn",
                    "suffix": ""
                },
                {
                    "first": "MD",
                    "middle": [],
                    "last": "Cooper",
                    "suffix": ""
                }
            ],
            "year": 2001,
            "venue": "J Exp Med",
            "volume": "194",
            "issn": "",
            "pages": "417-25",
            "other_ids": {
                "DOI": [
                    "10.1084/jem.194.4.417"
                ]
            }
        }
    }
}